Edgar Filing: Verisk Analytics, Inc.

Large accelerated filer

Accelerated filer

Non-accelerated filer

☐ (Do not check if a smaller reporting company)

Smaller reporting company

Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________

FORM 10-Q

___________________________________



☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2016



☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-34480

___________________________________

VERISK ANALYTICS, INC.

(Exact name of registrant as specified in its charter)

___________________________________



Delaware		26-2994223
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

545 Washington Boulevard Jersey City, NJ		07310-1686
(Address of principal executive offices)		(Zip Code)

(201) 469-2000

(Registrant’s telephone number, including area code)

___________________________________

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of October 28, 2016, there were 167,450,965 shares outstanding of the registrant's Common Stock, par value $.001.

Table of Contents

Verisk Analytics, Inc.

Index to Form 10-Q

Table of Contents



	Page Number

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

Condensed Consolidated Balance Sheets	1

Condensed Consolidated Statements of Operations	2

Condensed Consolidated Statements of Comprehensive Income	3

Condensed Consolidated Statements of Changes in Stockholders’ Equity	4

Condensed Consolidated Statements of Cash Flows	5

Notes to Condensed Consolidated Financial Statements	6

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	27

Item 3. Quantitative and Qualitative Disclosures About Market Risk	40

Item 4. Controls and Procedures	40

PART II — OTHER INFORMATION

Item 1. Legal Proceedings	41

Item 1A. Risk Factors	41

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	41

Item 3. Defaults Upon Senior Securities	41

Item 4. Mine Safety Disclosures	42

Item 5. Other Information	42

Item 6. Exhibits	42

SIGNATURES	43

Exhibit 31.1

Exhibit 31.2

Exhibit 32.1

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

VERISK ANALYTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

As of September 30, 2016 and December 31, 2015



	2016			2015

	(In thousands, except for share and per share data)
ASSETS
Current assets:
Cash and cash equivalents	$	164,787		$	138,348
Available-for-sale securities		3,457			3,576
Accounts receivable, net of allowance for doubtful accounts of $3,119 and $2,642, respectively		229,939			250,947
Prepaid expenses		28,616			34,126
Income taxes receivable		11,236			48,596
Other current assets		26,266			52,913
Current assets held-for-sale		—			76,063
Total current assets		464,301			604,569
Noncurrent assets:
Fixed assets, net		355,867			350,311
Intangible assets, net		1,069,089			1,245,083
Goodwill		2,632,178			2,753,026
Pension assets		42,524			32,922
Other assets		121,092			25,845
Noncurrent assets held-for-sale		—			581,896
Total assets	$	4,685,051		$	5,593,652

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$	192,301		$	222,112
Short-term debt and current portion of long-term debt		6,899			874,811
Pension and postretirement benefits, current		1,831			1,831
Deferred revenues		355,459			340,833
Current liabilities held-for-sale		—			39,670
Total current liabilities		556,490			1,479,257
Noncurrent liabilities:
Long-term debt		2,279,443			2,270,904
Pension benefits		12,526			12,971
Postretirement benefits		1,407			1,981
Deferred income taxes, net		305,694			329,175
Other liabilities		54,061			58,360
Noncurrent liabilities held-for-sale		—			68,993
Total liabilities		3,209,621			4,221,641
Commitments and contingencies
Stockholders’ equity:
Common stock, $.001 par value; 2,000,000,000 shares authorized; 544,003,038 shares issued and 168,340,643 and 169,424,981 shares outstanding, respectively		137			137
Additional paid-in capital		2,100,989			2,023,390
Treasury stock, at cost, 375,662,395 and 374,578,057 shares, respectively		(2,750,440	)		(2,571,190	)
Retained earnings		2,643,678			2,161,726
Accumulated other comprehensive losses		(518,934	)		(242,052	)
Total stockholders’ equity		1,475,430			1,372,011
Total liabilities and stockholders’ equity	$	4,685,051		$	5,593,652

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

VERISK ANALYTICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

For The Three and Nine Months Ended September 30, 2016 and 2015



	Three Months Ended September 30,						Nine Months Ended September 30,
	2016			2015			2016			2015

	(In thousands, except for share and per share data)
Revenues	$	498,081		$	470,408		$	1,489,077		$	1,283,300
Expenses:
Cost of revenues (exclusive of items shown separately below)		169,665			162,874			521,408			451,298
Selling, general and administrative		77,814			70,642			224,408			202,692
Depreciation and amortization of fixed assets		29,501			27,105			90,776			69,169
Amortization of intangible assets		22,679			12,639			70,355			42,998
Total expenses		299,659			273,260			906,947			766,157
Operating income		198,422			197,148			582,130			517,143
Other income (expense):
Investment income and others, net		2,124			17,894			3,014			17,134
Gain on derivative instruments		—			—			—			85,187
Interest expense		(28,150	)		(33,003	)		(91,617	)		(88,927	)
Total other income (expense), net		(26,026	)		(15,109	)		(88,603	)		13,394
Income from continuing operations before income taxes		172,396			182,039			493,527			530,537
Provision for income taxes		(44,819	)		(57,858	)		(149,484	)		(151,066	)
Income from continuing operations		127,577			124,181			344,043			379,471
Discontinued operations:
Income from discontinued operations		—			11,750			256,525			23,770
Provision for income taxes from discontinued operations		—			(4,117	)		(118,616	)		(9,421	)
Income from discontinued operations		—			7,633			137,909			14,349
Net income	$	127,577		$	131,814		$	481,952		$	393,820
Basic net income per share:
Income from continuing operations	$	0.76		$	0.74		$	2.04		$	2.32
Income from discontinued operations		—			0.04			0.82			0.09
Basic net income per share	$	0.76		$	0.78		$	2.86		$	2.41
Diluted net income per share:
Income from continuing operations	$	0.74		$	0.73		$	2.01		$	2.27
Income from discontinued operations		—			0.04			0.80			0.09
Diluted net income per share	$	0.74		$	0.77		$	2.81		$	2.36
Weighted average shares outstanding:
Basic		168,874,129			168,739,437			168,541,399			163,656,387
Diluted		171,785,900			172,171,337			171,495,189			167,079,550

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

VERISK ANALYTICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

For The Three and Nine Months Ended September 30, 2016 and 2015



	Three Months Ended September 30,						Nine Months Ended September 30,
	2016			2015			2016			2015

	(In thousands)
Net income	$	127,577		$	131,814		$	481,952		$	393,820
Other comprehensive loss, net of tax:
Foreign currency translation adjustment		(62,091	)		(95,843	)		(278,612	)		(100,272	)
Unrealized holding gain (loss) on available-for-sale securities		90			(22	)		293			47
Pension and postretirement liability adjustment		210			321			1,437			1,322
Total other comprehensive loss		(61,791	)		(95,544	)		(276,882	)		(98,903	)
Comprehensive income	$	65,786		$	36,270		$	205,070		$	294,917

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

VERISK ANALYTICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)

For The Year Ended December 31, 2015 and The Nine Months Ended September 30, 2016



	Common Stock Issued	Par Value		Unearned KSOP Contributions			Additional Paid-in Capital			Treasury Stock			Retained Earnings		Accumulated Other Comprehensive Losses			Total Stockholders’ Equity

	(In thousands, except for share data)
Balance, January 1, 2015	544,003,038	$	137	$	(161	)	$	1,171,196		$	(2,533,764	)	$	1,654,149	$	(80,514	)	$	211,043
Net income	—		—		—			—			—			507,577		—			507,577
Other comprehensive loss	—		—		—			—			—			—		(161,538	)		(161,538	)
Treasury stock acquired (1,088,474 shares)	—		—		—			100,000			(120,456	)		—		—			(20,456	)
KSOP shares earned (47,686 shares reissued from treasury stock)	—		—		161			13,588			327			—		—			14,076
Shares issued from equity offering (10,604,000 shares reissued from treasury stock)	—		—		—			651,258			69,590			—		—			720,848
Stock options exercised, including tax benefit of $27,992 (1,739,847 shares reissued from treasury stock)	—		—		—			57,503			11,730			—		—			69,233
Restricted stock lapsed, including tax benefit of $1,238 (177,252 shares reissued from treasury stock)	—		—		—			68			1,170			—		—			1,238
Employee stock purchase plan (25,599 shares reissued from treasury stock)	—		—		—			1,625			173			—		—			1,798
Stock based compensation	—		—		—			30,116			—			—		—			30,116
Net share settlement from restricted stock awards (32,882 shares withheld for tax settlement)	—		—		—			(2,350	)		—			—		—			(2,350	)
Other stock issuances (5,844 shares reissued from treasury stock)	—		—		—			386			40			—		—			426
Balance, December 31, 2015	544,003,038		137		—			2,023,390			(2,571,190	)		2,161,726		(242,052	)		1,372,011
Net income	—		—		—			—			—			481,952		—			481,952
Other comprehensive loss	—		—		—			—			—			—		(276,882	)		(276,882	)
Treasury stock acquired (2,561,814 shares)	—		—		—			—			(189,807	)		—		—			(189,807	)
KSOP shares issued (143,439 shares reissued from treasury stock)	—		—		—			10,354			1,032			—		—			11,386
Stock options exercised, including tax benefit of $17,217 (1,116,483 shares reissued from treasury stock)	—		—		—			45,137			7,973			—		—			53,110
Restricted stock lapsed, including tax benefit of $1,193 (168,280 shares reissued from treasury stock)	—		—		—			(9	)		1,202			—		—			1,193
Employee stock purchase plan (23,168 shares reissued from treasury stock)	—		—		—			1,609			167			—		—			1,776
Stock based compensation	—		—		—			23,712			—			—		—			23,712
Net share settlement of restricted stock awards (38,250 shares withheld for tax settlement)	—		—		—			(3,065	)		—			—		—			(3,065	)
Other stock issuances (26,106 shares reissued from treasury stock)	—		—		—			(139	)		183			—		—			44
Balance, September 30, 2016	544,003,038	$	137	$	—		$	2,100,989		$	(2,750,440	)	$	2,643,678	$	(518,934	)	$	1,475,430

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

VERISK ANALYTICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

For The Nine Months Ended September 30, 2016 and 2015



	2016			2015

	(In thousands)
Cash flows from operating activities:
Net income	$	481,952		$	393,820
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of fixed assets		97,832			86,571
Amortization of intangible assets		76,259			61,496
Amortization of debt issuance costs and original issue discount		3,999			11,770
Allowance for doubtful accounts		1,483			1,151
KSOP compensation expense		11,386			10,575
Stock based compensation		23,822			25,471
Gain on derivative instruments		—			(85,187	)
Gain on sale of discontinued operations		(269,385	)		—
Realized loss on available-for-sale securities, net		311			19
Gain on exercise of common stock warrants		(1,464	)		(15,602	)
Deferred income taxes		(1,733	)		1,498
Loss (gain) on disposal of fixed assets, net		851			(2	)
Excess tax benefits from exercised stock options and restricted stock awards		(20,763	)		(18,214	)
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable		32,608			39,651
Prepaid expenses and other assets		(15,053	)		2,662
Income taxes		45,258			44,716
Accounts payable and accrued liabilities		(7,205	)		(1,175	)
Deferred revenues		14,655			(30,772	)
Pension and postretirement benefits		(7,972	)		(10,552	)
Other liabilities		(3,170	)		2,148
Net cash provided by operating activities		463,671			520,044
Cash flows from investing activities:
Acquisitions, net of cash acquired of $1,034 and $35,398, respectively		(45,161	)		(2,811,759	)
Purchase of non-controlling interest in non-public companies		—			(101	)
Sale of non-controlling equity investments in non-public companies		8,464			101
Proceeds from sale of discontinued operations		719,374			—
Escrow funding associated with acquisition		(4,444	)		(78,694	)
Proceeds from the settlement of derivative instruments		—			85,187
Capital expenditures		(98,570	)		(105,765	)
Purchases of available-for-sale securities		(158	)		(54	)
Proceeds from sales and maturities of available-for-sale securities		441			281
Other investing activities, net		(620	)		—
Cash received from exercise of common stock warrants		—			15,602
Net cash provided by (used in) investing activities		579,326			(2,895,202	)
Cash flows from financing activities:
Proceeds from issuance of long-term debt, net of original issue discount		—			1,243,966
Repayment of short-term debt, net		(870,000	)		(90,000	)
Proceeds from issuance of short-term debt with original maturities greater than three months		—			830,000
Repayment of current portion of long-term debt		—			(170,000	)
Repayment of long-term debt		—			(50,000	)
Payment of debt issuance costs		(475	)		(23,942	)
Repurchases of common stock		(182,533	)		—
Excess tax benefits from exercised stock options and restricted stock awards		20,763			18,214
Proceeds from stock options exercised		32,591			31,283
Proceeds from issuance of stock as part of a public offering		—			720,848
Net share settlement of restricted stock awards		(3,065	)		(2,350	)
Other financing activities, net		(4,399	)		(4,784	)
Net cash (used in) provided by financing activities		(1,007,118	)		2,503,235
Effect of exchange rate changes		(9,440	)		1,389
Increase in cash and cash equivalents		26,439			129,466
Cash and cash equivalents, beginning of period		138,348			39,359
Cash and cash equivalents, end of period	$	164,787		$	168,825
Supplemental disclosures:
Taxes paid	$	221,419		$	111,867
Interest paid	$	75,845		$	56,583
Noncash investing and financing activities:
Repurchase of common stock included in accounts payable and accrued liabilities	$	7,274		$	—
Promissory note received for sale of discontinued operations	$	82,900		$	—
Equity interest received for sale of discontinued operations	$	8,400		$	—
Deferred tax liability established on date of acquisition	$	3,765		$	258,976
Tenant improvement included in other liabilities	$	74		$	1,168
Capital lease obligations	$	11,502		$	1,158
Capital expenditures included in accounts payable and accrued liabilities	$	2,336		$	605

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

VERISK ANALYTICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(Amounts in thousands, except for share and per share data, unless otherwise stated)

1. Organization:

Verisk Analytics, Inc. and its consolidated subsidiaries (“Verisk” or the “Company”) enable risk-bearing businesses to better understand and manage their risks. The Company provides its customers proprietary data that, combined with analytic methods, create embedded decision support solutions. The Company is one of the largest aggregators and providers of data pertaining to property and casualty (“P&C”) insurance risks in the United States of America (“U.S.”). The Company offers predictive analytics and decision support solutions to customers in rating, underwriting, claims, catastrophe and weather risk, global risk analytics, natural resources intelligence, economic forecasting, and many other fields.

Verisk was established to serve as the parent holding company of Insurance Services Office, Inc. (“ISO”) upon completion of the initial public offering ("IPO"), which occurred on October 9, 2009. ISO was formed in 1971 as an advisory and rating organization for the P&C insurance industry to provide statistical and actuarial services, to develop insurance programs and to assist insurance companies in meeting state regulatory requirements. For over the past decade, the Company has broadened its data assets, entered new markets, placed a greater emphasis on analytics, and pursued strategic acquisitions. Verisk trades under the ticker symbol “VRSK” on the NASDAQ Global Select Market.

2. Basis of Presentation and Summary of Significant Accounting Policies:

The accompanying unaudited condensed consolidated financial statements have been prepared on the basis of accounting principles generally accepted in the U.S. (“U.S. GAAP”). The preparation of financial statements in conformity with these accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates include acquisition purchase price allocations, the fair value of goodwill, the realization of deferred tax assets and liabilities, fair value of stock based compensation, assets and liabilities for pension and postretirement benefits, and the estimate for the allowance for doubtful accounts. Actual results may ultimately differ from those estimates. On March 31, 2016, the Company's healthcare business qualified as assets held-for-sale. Accordingly, the respective assets and liabilities have been classified as held-for-sale in the condensed consolidated balance sheet at December 31, 2015. The Company's healthcare business was sold on June 1, 2016. The results of operations and the gain on sale of the Company's healthcare business are reported as a discontinued operation for the periods presented herein (See Note 6).

The condensed consolidated financial statements as of September 30, 2016 and for the three and nine months ended September 30, 2016 and 2015, in the opinion of management, include all adjustments, consisting of normal recurring items, to present fairly the Company’s financial position, results of operations and cash flows. The operating results for the three and nine months ended September 30, 2016 are not necessarily indicative of the results to be expected for the full year. The condensed consolidated financial statements and related notes for the three and nine months ended September 30, 2016 have been prepared on the same basis as and should be read in conjunction with the annual report on Form 10-K for the year ended December 31, 2015. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules of the Securities and Exchange Commission (“SEC”). The Company believes the disclosures made are adequate to keep the information presented from being misleading.

Recent Accounting Pronouncements

In April 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2015-03. The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The Company adopted the guidance on January 1, 2016 and as a result, debt issuance costs of $22,275 were reclassified from "Other assets" to "Long-term debt" on the Company's condensed consolidated balance sheet as of December 31, 2015.

In April 2015, the FASB issued ASU No. 2015-05, Customer's Accounting for Fees Paid in a Cloud Computing Arrangement ("ASU No. 2015-05"). This guidance is intended to help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement, primarily to determine whether the arrangement includes a sale or license of software. The Company adopted the guidance on January 1, 2016. The adoption of ASU No. 2015-05 did not have a material impact on the Company's condensed consolidated financial statements.

Table of Contents

In September 2015, the FASB issued ASU No. 2015-16, Simplifying the Accounting for Measurement-Period Adjustments ("ASU No. 2015-16"). ASU No. 2015-16 requires, for business combinations, that the acquirer record, in the same period's financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. The Company adopted the guidance on January 1, 2016. Adoption of this guidance did not have a material impact on the results of operations or financial position (see Note 5).

In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU No. 2016-01”). The amendments in this update require all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under equity method of accounting or those that result in consolidation of the investee). The amendments allow equity investments that do not have readily determinable fair values to be remeasured at fair value either upon occurrence of an observable price change or upon identification of an impairment. The amendments in ASU No. 2016-01 are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. For amendments applicable to the Company, early adoption is not permitted. The Company will conform to ASC No. 2016-01 in the condensed consolidated financial statements in future periods.

In February 2016, the FASB issued ASU No. 2016-02, Leases ("ASU No. 2016-02"). This ASU amends the existing accounting considerations and treatments for leases through the creation of Topic 842, Leases, to increase transparency and comparability among organizations by requiring the recognition of lease assets and lease liabilities on the balance sheet and disclosing key information about lease arrangements. The amendments in ASU No. 2016-02 are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application of the amendments is permitted for all entities. The Company has decided not to early adopt ASU No. 2016-02 and is currently evaluating the impact the amendments may have on its condensed consolidated financial statements.

In March 2016, the FASB issued ASU No. 2016-07, Equity Method and Joint Ventures (“ASU No. 2016-07”). The amendments in the update eliminate the requirement that an entity retroactively adopt the equity method of accounting if an investment qualifies for use of the equity method as a result of an increase in the level of ownership or degree of influence. The amendments require that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor’s previously held interest and adopt the equity method of account as of the date the investment becomes qualified for equity method accounting. The amendments in ASU No. 2016-07 are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The Company has not elected to early adopt. The adoption of ASU No. 2016-07 is not expected to have a material impact on the Company’s condensed consolidated financial statements.

In March 2016, the FASB issued ASU No. 2016-08, Principal Versus Agent Considerations (“ASU No. 2016-08”). The amendments to this update are intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations. The amendments in ASU No. 2016-08 are effective for annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The Company is currently evaluating ASU No. 2016-08 and has not determined the impact this standard may have on its condensed consolidated financial statements nor decided upon the method of adoption.

In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting (“ASU No. 2016-09”). The objective of this update is to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The amendments in ASU No. 2016-09 are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted for any entity in any interim or annual period. The Company has not elected to early adopt. The Company is currently evaluating ASU No. 2016-09 and has not determined the impact these amendments may have on its condensed consolidated financial statements.

In April 2016, the FASB issued ASU No. 2016-10, Identifying Performance Obligations and Licensing (“ASU No. 2016-10”). The amendments in this update clarify the following two aspects of Accounting Standards Codification ("ASC") 606 ("ASC 606"), Revenue From Contracts With Customers: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The amendments in ASU No. 2016-10 are effective for annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The Company has not elected to early adopt. The Company is currently evaluating ASU No. 2016-10 and has not determined the impact this standard may have on its condensed consolidated financial statements nor decided upon the method of adoption.

Table of Contents

In May 2016, the FASB issued ASU No. 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF Meeting (SEC Update) ("ASU No. 2016-11"). Specifically, registrants should not rely on the following SEC Staff Observer comments upon adoption of ASC 606: a. Revenue and Expense Recognition for Freight Services in Process, b. Accounting for Shipping and Handling Fees and Costs, c. Accounting for Consideration Given by a Vendor to a Customer, and d. Accounting for Gas-Balancing Arrangements. The adoption of ASU No. 2016-11 is not expected to have a material impact on the Company’s condensed consolidated financial statements.

In May 2016, the FASB issued ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients ("ASU No. 2016-12"). ASU No. 2016-12 does not change the core principle of the guidance in ASC 606. Rather, this update affects only the narrow scope improvements to the guidance on collectability, noncash consideration, and completed contracts at transition. The effective date and transition requirements for ASU 2016-12 are the same as the effective date and transition requirements for ASC 606. The adoption of ASU No. 2016-12 is not expected to have a material impact on the Company’s condensed consolidated financial statements.

In June 2016, the FASB issued ASU No. 2016-13, Measurement of Credit Losses on Financial Instruments ("ASU No. 2016-13"). Financial assets measured at amortized cost basis, including but not limited to loans, debt securities and trade receivables , that have the contractual right to receive cash are within the scope of this guidance. Under ASU No. 2016-13, these financial assets should be presented at the net amount expected to be collected. The income statement should reflect the measurement of credit losses that have taken place during the period. The amendments in ASU No. 2016-13 are effective for fiscal years beginning after December 15, 2019. Earlier adoption is permitted. The Company has decided not to early adopt ASU No. 2016-13. The adoption of ASU No. 2016-13 is not expected to have a material impact on the Company’s condensed consolidated financial statements.

In August 2016, the FASB issued ASU No. 2016-15, Classification of Certain Cash Receipts and Cash Payments ("ASU No. 2016-15"). The amendments in this update provide guidance on various specific cash flow issues to reduce diversity in the practice of how certain transactions are classified in the statement of cash flows. ASU No. 2016-15 is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The Company has not elected to early adopt. The Company is currently evaluating ASU No. 2016-15 and has not yet determined the impact these amendments may have on its condensed consolidated financial statements.

3. Investments:

Available-for-sale securities consisted of the following:



	Adjusted Cost		Gross Unrealized Gain (Loss)			Fair Value
September 30, 2016
Registered investment companies	$	3,029	$	428		$	3,457
December 31, 2015
Registered investment companies	$	3,622	$	(46	)	$	3,576

In addition to the available-for-sale securities above, the Company has equity investments in non-public companies in which the Company acquired non-controlling interests and for which no readily determinable market value exists. These securities were accounted for in accordance with ASC 323-10-25, The Equity Method of Accounting for Investments in Common Stock ("ASC 323-10-25"). At September 30, 2016 and December 31, 2015, the carrying value of such securities was $9,887 and $8,487, respectively, and has been included in “Other assets” in the accompanying condensed consolidated balance sheets.

4. Fair Value Measurements:

Certain assets and liabilities of the Company are reported at fair value in the accompanying condensed consolidated balance sheets. To increase consistency and comparability of assets and liabilities recorded at fair value, ASC 820-10, Fair Value Measurements (“ASC 820-10”), established a three-level fair value hierarchy to prioritize the inputs to valuation techniques used to measure fair value. ASC 820-10 requires disclosures detailing the extent to which companies measure assets and liabilities at fair value, the methods and assumptions used to measure fair value and the effect of fair value measurements on earnings. In accordance with ASC 820-10, the Company applied the following fair value hierarchy:

Table of Contents



Level 1 -		Assets or liabilities for which the identical item is traded on an active exchange, such as publicly-traded instruments.

Level 2 -		Assets and liabilities valued based on observable market data for similar instruments.

Level 3 -		Assets or liabilities for which significant valuation assumptions are not readily observable in the market; instruments valued based on the best available data, some of which are internally-developed, and considers risk premiums that market participants would require.

The fair values of cash and cash equivalents, accounts receivable, securities accounted for under ASC 323-10-25, accounts payable and accrued liabilities, and short-term debt approximate their carrying amounts because of the short-term nature of these instruments.

The following table summarizes fair value measurements by level for cash equivalents and registered investment companies that were measured at fair value on a recurring basis:



	Quoted Prices in Active Markets for Identical Assets (Level 1)
September 30, 2016
Registered investment companies (1)	$	3,457
December 31, 2015
Registered investment companies (1)	$	3,576

______________________

(1) Registered investment companies are classified as available-for-sale securities and are valued using quoted prices in active markets multiplied by the number of shares owned.

The Company has not elected to carry its long-term debt at fair value. The carrying value of the long-term debt represents amortized cost less unamortized discount and debt issuance costs. The Company assesses the fair value of its long-term debt based on quoted market prices if available, and if not, an estimate of interest rates available to the Company for debt with similar features, the Company’s current credit rating and spreads applicable to the Company. The following table summarizes the carrying value and estimated fair value of the long-term debt as of September 30, 2016 and December 31, 2015, respectively:



		2016				2015
	Fair Value Hierarchy	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
Financial instrument not carried at fair value:
Subordinated promissory note receivable	Level 2	$	83,613	$	80,400	$	—	$	—
Long-term debt excluding capitalized leases	Level 2	$	2,276,578	$	2,485,280	$	2,274,144	$	2,328,134

5. Acquisitions:

2016 Acquisitions

On August 19, 2016, the Company acquired the data and subscriptions business of Quest Offshore Resources, Inc. ("Quest Offshore"), which supplies market intelligence to the offshore oil and gas sector, for a net cash purchase price of $8,000, including a holdback of $792. The data and subscriptions business has become part of Wood Mackenzie Limited ("Wood Mackenzie") within the Decision Analytics segment and complements its existing upstream analysis expertise.

On July 26, 2016, the Company acquired 100 percent of the stock of Greentech Media, Inc. (“Greentech Media”), an information services provider for the electricity and renewables sector, for a net cash purchase price of $36,192, of which $4,440 represents indemnity escrows. The cash paid will be adjusted subsequent to close to reflect final balances of certain working capital accounts and other closing adjustments. Greentech Media has become part of Wood Mackenzie within the Decision Analytics segment and enables Wood Mackenzie to provide its clients with market intelligence across several categories, including solar generation, energy storage, and smart grids that react to changes in supply and demand.

On April 14, 2016, the Company acquired 100 percent of the stock of Risk Intelligence Ireland ("RII"), a provider of fraud detection, compliance, risk control, and process automation services to the Irish insurance industry, for a net cash purchase price of $6,200. RII enhances the ability of the Company's Risk Assessment segment to serve the international insurance market.

Table of Contents

The preliminary allocations of the purchase price of these acquisitions are subject to revisions as additional information is obtained about the facts and circumstances that existed as of each acquisition date. The revisions may have a significant impact on the condensed consolidated financial statements. The allocations of the purchase price will be finalized once all information is obtained, but not to exceed one year from the acquisition date. The primary areas of the purchase price allocation that are not yet finalized relate to fixed assets and operating leases, income and non-income taxes, deferred revenues, the valuation of intangible assets acquired, and residual goodwill. The preliminary amounts assigned to intangible assets by type for these acquisitions were based upon the Company's valuation model and historical experiences with entities with similar business characteristics.

The goodwill associated with the stock purchases of Greentech Media and RII is not deductible for tax purposes; whereas the goodwill associated with the asset purchase of Quest Offshore is deductible for tax purposes. For the three and nine months ended September 30, 2016, the Company incurred transaction costs related to these acquisitions of $835 and $1,003, respectively, included within "Selling, general and administrative" expenses in the accompanying condensed consolidated statements of operations.

2015 Acquisitions

On May 19, 2015, the Company acquired 100 percent of the stock of Wood Mackenzie for a net cash purchase price of $2,889,629, including $78,694 of an indemnity escrow, which the Company financed through a combination of debt and equity offerings, borrowings under the Company's credit facility, and cash on hand. Due to the fact that a portion of the purchase price was funded in pounds sterling and the remainder in U.S. dollars, the Company entered into a foreign currency hedging instrument to purchase pounds sterling. The Company recorded a gain on the hedge of $85,187 for the nine months ended September 30, 2015. The proceeds from the gain were utilized to partially fund the acquisition of Wood Mackenzie. Wood Mackenzie is a global provider of data analytics and commercial intelligence for the energy, chemicals, metals and mining verticals. This acquisition advances the Company’s strategy to expand internationally and positions the Company in the global energy market. Wood Mackenzie is included in the energy and specialized markets vertical, formerly named the specialized markets vertical, of the Decision Analytics segment.

As of June 30, 2016, the Company finalized the purchase accounting for the acquisition of Wood Mackenzie. The final purchase price allocations of the acquisition resulted in the following:



	Wood Mackenzie
Cash and cash equivalents	$	35,398
Accounts receivable		80,307
Current assets		97,397
Fixed assets		71,929
Intangible assets		1,111,950
Goodwill and other		2,002,418
Other assets		1,993
Total assets acquired		3,401,392
Current liabilities		121,996
Deferred revenues		142,457
Deferred income taxes, net		204,289
Other liabilities		7,623
Total liabilities assumed		476,365
Net assets acquired		2,925,027
Cash acquired		(35,398	)
Net cash purchase price	$	2,889,629

The impact of finalization of the purchase accounting for Wood Mackenzie was not material to the condensed consolidated statements of operations for the three and nine months ended September 30, 2016 and 2015.

Table of Contents

The Company determined the fair values of the assets and liabilities of Wood Mackenzie with the assistance of valuations performed by third party specialists, discounted cash flow analysis and estimates made by management. The final amounts assigned to intangible assets by type for the Wood Mackenzie acquisition are summarized in the table below:



	Weighted Average Useful Life	Total
Technology-related	7 years	$	104,663
Marketing-related	20 years		232,935
Customer-related	15 years		278,106
Database-related	20 years		496,246
Total intangible assets		$	1,111,950

On November 6, 2015, the Company acquired 100 percent of the stock of Infield Systems Limited ("Infield"). Infield is a provider of business intelligence, analysis, and research to the oil, gas, and associated marine industries. Infield has become part of Wood Mackenzie and continues to provide services to enhance Wood Mackenzie's upstream and supply chain capabilities in the Decision Analytics segment. The Company paid a net cash purchase price of $13,804.

On November 20, 2015, the Company acquired 100 percent of the stock of The PCI Group ("PCI"). PCI is a consortium of five specialist companies that offer integrated data and subscriptions research in the chemicals, fibers, films, and plastics sectors. PCI has become part of Wood Mackenzie and continues to provide services to enhance Wood Mackenzie's chemicals capabilities in the Decision Analytics segment. The Company paid a net cash purchase price of $37,387.

The preliminary allocations of the purchase prices for the acquisitions of Infield and PCI are subject to revisions as additional information is obtained about the facts and circumstances that existed as of the acquisition dates. The revisions may have a significant impact on the condensed consolidated financial statements. The allocations of the purchase prices will be finalized during the quarter ending December 31, 2016. The primary areas of the purchase price allocations that are not yet finalized relate to fixed assets and operating leases, income and non-income taxes, deferred revenues, the valuation of intangible assets acquired, and residual goodwill.

The goodwill associated with the stock purchases of Wood Mackenzie, Infield and PCI is not deductible for tax purposes. For the nine months ended September 30, 2015, the Company incurred transaction costs related to the Wood Mackenzie acquisition of $26,617 included within "Selling, general and administrative" expenses and $13,336 included within "Interest expense" in the accompanying condensed consolidated statements of operations.

Acquisition Escrows

Pursuant to the related acquisition agreements, the Company has funded various escrow accounts to satisfy pre-acquisition indemnity and tax claims arising subsequent to the acquisition date, as well as a portion of the contingent payments. At September 30, 2016 and December 31, 2015, the current portion of the escrows amounted to $9,180 and $38,656, and the noncurrent portion of the escrows amounted to $0 and $4,591, respectively. The current and noncurrent portions of the escrows have been included in “Other current assets” and "Other assets" in the accompanying condensed consolidated balance sheets, respectively.

6. Discontinued Operations:

On June 1, 2016, the Company sold 100 percent of the stock of its healthcare business, Verisk Health ("Verisk Health"), in exchange for a purchase price that consisted of $719,374 of cash consideration after a working capital adjustment of $626, a subordinated promissory note with a face value of $100,000 and an eight year maturity (the "Note"), and other contingent consideration (collectively, the "Sale"). The Company recognized income from the discontinued operation, net of tax, of $0 and $137,909 for the three and nine months ended September 30, 2016, respectively. Results of operations for the healthcare business are reported as a discontinued operation for the three and nine months ended September 30, 2016 and for all prior periods presented.

The Note has a stated interest rate of 9.0% per annum, increasing to 11.0% per annum at the earlier of specified refinancings or acquisitions, or the fourth anniversary of the closing of the Sale. Interest shall accrue from the closing date and on each anniversary of the Sale until the Note is paid in full on the unpaid principal amount of the Note outstanding at the interest rate in effect (computed on the basis of a 360-day year of twelve 30-day months). On each anniversary of the Sale, accrued interest shall be paid in kind by adding the amount of such accrued interest to the outstanding principal amount of the Note. The issuer of the Note may, at its option at any time prior to the maturity date, prepay any, or all, of the principal amount of the Note, plus accrued but unpaid interest as of the elected prepayment date, without any premium or penalty. There is a mandatory prepayment of the Note as a result of

Table of Contents

(i) the proceeds of a specified dividend recapitalization received by the issuer, (ii) the consummation of a change of control of the issuer, or (iii) the sale, transfer or other disposition by the parent of the issuer of more than 10.0% of the capital stock of the issuer. As of September 30, 2016, the Company had a receivable of $83,613 outstanding under the Note. The fair value of the Note is based on management estimates with the assistance of valuations performed by third party specialists, discounted cash flow analysis based on current market conditions and assumptions that the Note would be paid in full at maturity, including accrued interest, with no prepayment election.

The Company also received a 10.0% non-participating interest in the issuer's stock, the exercise value of which will be contingent on the parent of the issuer realizing a specified rate of return on its investment. As of September 30, 2016, the Company had an equity investment of $8,400 related to such interest accounted for in accordance with ASC 323-10-25. The value of the equity investment is based on management estimates with the assistance of valuations performed by third party specialists. Refer to Note 3. Investments for further discussion.

The following table summarizes the results from the discontinued operation for the three and nine months ended September 30:



	Three Months Ended September 30,					Nine Months Ended September 30,
	2016		2015			2016			2015
Revenues from discontinued operations	$	—	$	79,993		$	112,323		$	224,148
Expenses:
Cost of revenues (exclusive of items shown separately below)		—		47,293			75,878			138,281
Selling, general and administrative		—		8,668			36,559			26,216
Depreciation and amortization of fixed assets		—		6,396			7,056			17,402
Amortization of intangible assets		—		5,904			5,904			18,498
Total expenses		—		68,261			125,397			200,397
Operating income		—		11,732			(13,074	)		23,751
Other income (expense):
Gain on sale		—		—			269,385			—
Investment income and others, net		—		18			214			19
Total other income		—		18			269,599			19
Income from discontinued operations before income taxes		—		11,750			256,525			23,770
Provision for income taxes (including tax on gain of $118,019)		—		(4,117	)		(118,616	)		(9,421	)
Income from discontinued operations, net of tax	$	—	$	7,633		$	137,909		$	14,349

Table of Contents

The following table summarizes the assets held-for-sale and the liabilities held-for-sale as of December 31, 2015:



	December 31, 2015
Accounts receivable, net of allowance for doubtful accounts of $2,428	$	69,152
Prepaid expenses		6,615
Income tax receivable		257
Other current assets		39
Total current assets held-for-sale	$	76,063

Fixed assets, net	$	67,857
Intangible assets, net		131,662
Goodwill		381,800
Other assets		577
Total noncurrent assets held-for-sale	$	581,896

Accounts payable and accrued liabilities	$	23,552
Deferred revenues		16,118
Total current liabilities held-for-sale	$	39,670

Deferred income taxes, net	$	67,255
Other liabilities		1,738
Total noncurrent liabilities held-for-sale	$	68,993

Net cash provided by operating activities and net cash used in investing activities from the discontinued operation for the nine months ended September 30 are presented below:



	Nine Months Ended September 30,
	2016			2015
Net cash provided by operating activities	$	21,443		$	52,521
Net cash used in investing activities	$	(10,649	)	$	(18,530	)

The Company has also entered into a transitional service agreement ("TSA") with the buyer of Verisk Health. Under the TSA, the Company provides various services for terms generally up to 12 months from the acquisition date and receives a level of cost reimbursement from the buyer.

7. Goodwill and Intangible Assets:

The following is a summary of the change in goodwill from December 31, 2015 through September 30, 2016, both in total and as allocated to the Company’s operating segments:



	Risk Assessment			Decision Analytics			Total
Goodwill at December 31, 2015 (1)	$	55,555		$	2,697,471		$	2,753,026
Current year acquisition		4,639			36,465			41,104
Purchase accounting reclassification		—			8,646			8,646
Foreign currency translation		(22	)		(170,576	)		(170,598	)
Goodwill at September 30, 2016 (1)	$	60,172		$	2,572,006		$	2,632,178

______________________


(1)	The balances at December 31, 2015 are net of the reclassification of goodwill to noncurrent assets held-for-sale of $381,800. Refer to Note 6. Discontinued Operations for further discussion.

Goodwill and intangible assets with indefinite lives are subject to impairment testing annually as of June 30, or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable. Goodwill impairment testing compares the carrying value of each reporting unit to its fair value. If the fair value of the reporting unit exceeds the carrying value of the net assets, including goodwill assigned to that reporting unit, goodwill is not impaired. If the carrying value of the reporting unit’s net assets including goodwill exceeds the fair value of the reporting unit, then the Company will determine the implied fair value of the reporting unit’s goodwill. If the carrying value of a reporting unit’s goodwill exceeds its implied fair value, then an

Table of Contents

impairment loss is recorded for the difference between the carrying amount and the implied fair value of goodwill. The Company completed the required annual impairment test as of June 30, 2016, and concluded that there was no impairment of goodwill.

The Company’s intangible assets and related accumulated amortization consisted of the following:



	Weighted Average Useful Life	Cost		Accumulated Amortization			Net
September 30, 2016
Technology-based	7 years	$	323,093	$	(191,682	)	$	131,411
Marketing-related	17 years		234,234		(45,387	)		188,847
Contract-based	6 years		4,996		(4,996	)		—
Customer-related	14 years		486,325		(121,122	)		365,203
Database-related	20 years		412,119		(28,491	)		383,628
Total intangible assets		$	1,460,767	$	(391,678	)	$	1,069,089
December 31, 2015
Technology-based	7 years	$	327,767	$	(175,746	)	$	152,021
Marketing-related	18 years		259,158		(37,798	)		221,360
Contract-based	6 years		4,996		(4,996	)		—
Customer-related	14 years		512,632		(96,549	)		416,083
Database-related	20 years		470,367		(14,748	)		455,619
Total intangible assets		$	1,574,920	$	(329,837	)	$	1,245,083

Amortization expense related to intangible assets for the three months ended September 30, 2016 and 2015 was $22,679 and $12,639, respectively. Amortization expense related to intangible assets for the nine months ended September 30, 2016 and 2015 was $70,355 and $42,998, respectively. Estimated amortization expense for the remainder of 2016 and the years through 2021 and thereafter for intangible assets subject to amortization is as follows:



Year	Amount
2016	$	22,653
2017		90,297
2018		90,165
2019		89,632
2020		88,952
2021 and thereafter		687,390
	$	1,069,089

8. Income Taxes:

The Company’s effective tax rate for the three and nine months ended September 30, 2016 was 26.00% and 30.29% , respectively, compared to the effective tax rate for the three and nine months ended September 30, 2015 of 31.78% and 28.47%. The effective tax rate for the three months ended September 30, 2016 is lower than the September 30, 2015 effective tax rate primarily due to tax benefits of legislation enacted in the United Kingdom lowering future income tax rates. The effective tax rate for the nine months ended September 30, 2016 is higher than the September 30, 2015 effective tax rate primarily due to non-recurring tax benefits related to the Wood Mackenzie acquisition in 2015. The difference between statutory tax rates and the Company’s effective tax rate is primarily attributable to state taxes and tax benefits related to the Wood Mackenzie acquisition.

Table of Contents

9. Debt:

The following table presents short-term and long-term debt by issuance as of September 30, 2016 and December 31, 2015:



	Issuance Date	Maturity Date	2016			2015
Short-term debt and current portion of long-term debt:
Syndicated revolving credit facility	Various	Various	$	—		$	870,000
Capital lease obligations	Various	Various		6,899			4,811
Short-term debt and current portion of long-term debt				6,899			874,811
Long-term debt:
Senior notes:
4.000% senior notes, less unamortized discount and debt issuance costs of $10,689 and $11,619, respectively	5/15/2015	6/15/2025		889,311			888,381
5.500% senior notes, less unamortized discount and debt issuance costs of $5,094 and $5,226, respectively	5/15/2015	6/15/2045		344,906			344,774
4.125% senior notes, less unamortized discount and debt issuance costs of $3,655 and $4,117, respectively	9/12/2012	9/12/2022		346,345			345,883
4.875% senior notes, less unamortized discount and debt issuance costs of $1,504 and $2,002, respectively	12/8/2011	1/15/2019		248,496			247,998
5.800% senior notes, less unamortized discount and debt issuance costs of $2,480 and $2,892, respectively	4/6/2011	5/1/2021		447,520			447,108
Capital lease obligations	Various	Various		7,332			2,317
Syndicated revolving credit facility debt issuance costs	Various	Various		(4,467	)		(5,557	)
Long-term debt				2,279,443			2,270,904
Total debt			$	2,286,342		$	3,145,715

As of September 30, 2016 and December 31, 2015, the Company had senior notes with an aggregate principal amount of $2,300,000 outstanding and was in compliance with their financial debt covenants.

As of September 30, 2016, the Company had a borrowing capacity of $1,500,000 under the committed senior unsecured Syndicated Revolving Credit Facility (the "Credit Facility") with Bank of America N.A., JP Morgan Chase, N.A., Sun Trust Bank, Wells Fargo Bank N.A., Citizens Bank, N.A., Morgan Stanley Senior Funding, Inc., HSBC Bank USA, N.A., Royal Bank of Canada, BNP Paribas, TD Bank, N.A., The Northern Trust Company, and Capital One N.A. The Credit Facility may be used for general corporate purposes, including working capital needs and capital expenditures, acquisitions and the share repurchase program (the "Repurchase Program"). The Company was in compliance with all financial debt covenants under the Credit Facility as of September 30, 2016. As of September 30, 2016 and December 31, 2015, the Company had outstanding borrowings under the Credit Facility of $0 and $870,000, respectively. During the nine months ended September 30, 2016, the Company utilized a portion of the proceeds from the sale of Verisk Health and cash flows from operations to repay the outstanding borrowings under the Credit Facility. On May 26, 2016, the Company entered into the Second Amendment to the Credit Facility, which reduced the borrowing capacity from $1,750,000 to $1,500,000 and amended the pricing grid.

10. Stockholders’ Equity:

The Company has 2,000,000,000 shares of authorized common stock. The common shares have rights to any dividend declared by the board of directors (the "Board"), subject to any preferential or other rights of any outstanding preferred stock, and voting rights to elect all fourteen members of the Board.

The Company has 80,000,000 shares of authorized preferred stock, par value $0.001 per share. The preferred shares have preferential rights over the common shares with respect to dividends and net distribution upon liquidation. The Company did not issue any preferred shares as of September 30, 2016.

Table of Contents

Share Repurchase Program

Since the introduction of the Repurchase Program as a feature of the Company's capital management strategies in 2010, the Company has authorized repurchases of up to $2,300,000 of its common stock and has repurchased shares with an aggregate value of $2,020,456. The Company repurchased 2,561,814 shares of common stock with an aggregate value of $189,807 during the nine months ended September 30, 2016. As of September 30, 2016, the Company had $279,545 available to repurchase shares. The Company has no obligation to repurchase stock under this program and intends to use this authorization as a means of offsetting dilution from the issuance of shares under the KSOP, the Verisk 2013 Equity Incentive Plan (the “2013 Incentive Plan”), the Verisk 2009 Equity Incentive Plan (the “2009 Incentive Plan”), and the ISO 1996 Incentive Plan (the “1996 Incentive Plan”), while providing flexibility to repurchase additional shares if warranted. This authorization has no expiration date and may be increased, reduced, suspended, or terminated at any time. Shares that are repurchased under the Repurchase Program will be recorded as treasury stock and will be available for future issuance.

Treasury Stock

As of September 30, 2016, the Company’s treasury stock consisted of 375,662,395 shares of common stock. During the nine months ended September 30, 2016, the Company reissued 1,477,476 shares of common stock from the treasury shares at a weighted average price of $7.15 per share.

Earnings Per Share (“EPS”)

Basic EPS is computed by dividing income from continuing operations, income from discontinued operations and net income, respectively, by the weighted average number of common shares outstanding during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding, using the treasury stock method, if the dilutive potential common shares, including stock options, nonvested restricted stock awards, and nonvested restricted stock units, had been issued.

The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations for the three and nine months ended September 30, 2016 and 2015:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2016		2015		2016		2015
Numerator used in basic and diluted EPS:
Income from continuing operations	$	127,577	$	124,181	$	344,043	$	379,471
Income from discontinued operations (Note 6)		—		7,633		137,909		14,349
Net income	$	127,577	$	131,814	$	481,952	$	393,820
Denominator:
Weighted average number of common shares used in basic EPS		168,874,129		168,739,437		168,541,399		163,656,387
Effect of dilutive shares:
Potential common shares issuable from stock options and stock awards		2,911,771		3,431,900		2,953,790		3,423,163
Weighted average number of common shares and dilutive potential common shares used in diluted EPS		171,785,900		172,171,337		171,495,189		167,079,550

The potential shares of common stock that were excluded from diluted EPS were 1,239,406 and 1,596,280 for the three months ended September 30, 2016 and 2015, and 1,890,460 and 1,127,414 for the nine months ended September 30, 2016 and 2015, respectively, because the effect of including these potential shares was anti-dilutive.

Table of Contents

Accumulated Other Comprehensive Losses

The following is a summary of accumulated other comprehensive losses as of September 30, 2016 and December 31, 2015:



	2016			2015
Foreign currency translation adjustment	$	(444,440	)	$	(165,828	)
Unrealized holding gains on available-for-sale securities, net of tax		296			3
Pension and postretirement adjustment, net of tax		(74,790	)		(76,227	)
Accumulated other comprehensive losses	$	(518,934	)	$	(242,052	)

The before tax and after tax amounts of other comprehensive income for the three and nine months ended September 30, 2016 and 2015 are summarized below:



	Before Tax			Tax Benefit (Expense)			After Tax
For the Three Months Ended September 30, 2016
Foreign currency translation adjustment	$	(62,091	)	$	—		$	(62,091	)
Unrealized holding gain on available-for-sale securities before reclassifications		731			(279	)		452
Amount reclassified from accumulated other comprehensive losses (1)		(585	)		223			(362	)
Unrealized holding gain on available-for-sale securities		146			(56	)		90
Pension and postretirement adjustment before reclassifications		1,821			(1,026	)		795
Amortization of net actuarial loss and prior service benefit reclassified from accumulated other comprehensive losses (2)		(938	)		353			(585	)
Pension and postretirement adjustment		883			(673	)		210
Total other comprehensive loss	$	(61,062	)	$	(729	)	$	(61,791	)
For the Three Months Ended September 30, 2015
Foreign currency translation adjustment	$	(95,843	)	$	—		$	(95,843	)
Unrealized holding loss on available-for-sale securities before reclassifications		(2	)		1			(1	)
Amount reclassified from accumulated other comprehensive losses (1)		(34	)		13			(21	)
Unrealized holding loss on available-for-sale securities		(36	)		14			(22	)
Pension and postretirement adjustment before reclassifications		1,574			(767	)		807
Amortization of net actuarial loss and prior service benefit reclassified from accumulated other comprehensive losses (2)		(787	)		301			(486	)
Pension and postretirement adjustment		787			(466	)		321
Total other comprehensive loss	$	(95,092	)	$	(452	)	$	(95,544	)

Table of Contents



		Before Tax			Tax Benefit (Expense)			After Tax
For the Nine Months Ended September 30, 2016
Foreign currency translation adjustment	$	(278,612	)	$	—		$	(278,612	)
Unrealized holding gain on available-for-sale securities before reclassifications		785			(300	)		485
Amount reclassified from accumulated other comprehensive losses (1)		(311	)		119			(192	)
Unrealized holding gain on available-for-sale securities		474			(181	)		293
Pension and postretirement adjustment before reclassifications		5,353			(2,243	)		3,110
Amortization of net actuarial loss and prior service benefit reclassified from accumulated other comprehensive losses (2)		(2,704	)		1,031			(1,673	)
Pension and postretirement adjustment		2,649			(1,212	)		1,437
Total other comprehensive loss	$	(275,489	)	$	(1,393	)	$	(276,882	)
For the Nine Months Ended September 30, 2015
Foreign currency translation adjustment	$	(100,272	)	$	—		$	(100,272	)
Unrealized holding gain on available-for-sale securities before reclassifications		94			(35	)		59
Amount reclassified from accumulated other comprehensive losses (1)		(19	)		7			(12	)
Unrealized holding gain on available-for-sale securities		75			(28	)		47
Pension and postretirement adjustment before reclassifications		4,862			(2,039	)		2,823
Amortization of net actuarial loss and prior service benefit reclassified from accumulated other comprehensive losses (2)		(2,431	)		930			(1,501	)
Pension and postretirement adjustment		2,431			(1,109	)		1,322
Total other comprehensive loss	$	(97,766	)	$	(1,137	)	$	(98,903	)

_______________


(1)	This accumulated other comprehensive loss component, before tax, is included under “Investment income and others, net” in the accompanying condensed consolidated statements of operations.


(2)	These accumulated other comprehensive loss components, before tax, are included under “Cost of revenues” and “Selling, general and administrative” in the accompanying condensed consolidated statements of operations. These components are also included in the computation of net periodic (benefit) cost (see Note 12 Pension and Postretirement Benefits for additional details).

11. Equity Compensation Plans:

All of the Company’s outstanding stock options and restricted stock awards are covered under the 2013 Incentive Plan, 2009 Incentive Plan or the 1996 Incentive Plan. Awards under the 2013 Incentive Plan may include one or more of the following types: (i) stock options (both nonqualified and incentive stock options), (ii) stock appreciation rights, (iii) restricted stock, (iv) restricted stock units, (v) performance awards, (vi) other share based awards, and (vii) cash. Employees, directors and consultants are eligible for awards under the 2013 Incentive Plan. The Company issued common stock under these plans from the Company’s treasury shares. As of September 30, 2016, there were 8,743,231 shares of common stock reserved and available for future issuance under the 2013 Incentive Plan. Cash received from stock option exercises for the nine months ended September 30, 2016 and 2015 was $32,591 and $31,283, respectively.

Table of Contents

The Company granted equity awards to key employees of the Company. The nonqualified stock options have an exercise price equal to the closing price of the Company’s common stock on the grant date, with a ten-year contractual term. The fair value of the restricted stock is determined using the closing price of the Company’s common stock on the grant date. The restricted stock is not assignable or transferable until it becomes vested. The Company recognizes the expense of the equity awards ratably over the vesting period. A summary of the equity awards granted for the nine months ended September 30, 2016 is presented below.



Grant Date	Service Vesting Period	Stock Options	Restricted Stock	Common Stock
April 1, 2016	Four-year graded vesting	1,219,096	244,244	—
April 1, 2016	Not applicable	—	—	567
April 4, 2016	Four-year graded vesting	2,212	415	—
April 18, 2016	Four-year graded vesting	1,266	239	—
April 25, 2016	Three-year graded vesting	3,344	946	—
May 2, 2016	Four-year graded vesting	12,931	2,438	—
May 3, 2016	Four-year graded vesting	3,379	632	—
June 6, 2016	Four-year graded vesting	4,029	751	—
July 1, 2016	Immediate vesting on grant date	26,417	1,112	—
July 1, 2016	One-year graded vesting	51,381	9,856	—
July 1, 2016	Not applicable		—	2,471
July 1, 2016	Four-year graded vesting	2,539	463	—
August 17, 2016	One-year graded vesting	8,094	1,546	—
		1,334,688	262,642	3,038

On October 3, 2016, the Company granted 30,228 nonqualified stock options and 5,583 shares of restricted stock to key employees. The nonqualified stock options have a service vesting period of four years.

The fair value of the stock options granted for the nine months ended September 30, 2016 and 2015 was estimated using a Black-Scholes valuation model that uses the weighted average assumptions noted in the following table:



	2016			2015
Option pricing model		Black-Scholes			Black-Scholes
Expected volatility		20.27	%		20.22	%
Risk-free interest rate		1.14	%		1.51	%
Expected term in years		4.5			4.5
Dividend yield		—	%		—	%
Weighted average grant date fair value per stock option	$	15.34		$	12.96

The expected term for the stock options granted was estimated based on studies of historical experience and projected exercise behavior. However, for certain awards granted, for which no historical exercise pattern exists, the expected term was estimated using the simplified method. The risk-free interest rate is based on the yield of U.S. Treasury zero coupon securities with a maturity equal to the expected term of the equity award. The volatility factor is calculated using historical daily closing prices over the most recent period that is commensurate with the expected term of the stock option award. The volatility factor for stock options granted in 2016 was based on the volatility of the Company's stock. The expected dividend yield was based on the Company’s expected annual dividend rate on the date of grant.

Table of Contents

A summary of the stock options outstanding and exercisable as of December 31, 2015 and September 30, 2016 and changes during the interim period are presented below:



	Number of Options		Weighted Average Exercise Price		Aggregate Intrinsic Value
Outstanding at December 31, 2015	9,117,733		$	40.17	$	334,691
Granted	1,334,688		$	80.20
Exercised	(1,116,483	)	$	32.15	$	53,678
Cancelled or expired	(265,335	)	$	72.86
Outstanding at September 30, 2016	9,070,603		$	46.09	$	319,231
Exercisable at September 30, 2016	6,349,450		$	35.06	$	293,440
Exercisable at December 31, 2015	6,541,229		$	29.81	$	307,924

Intrinsic value for stock options is calculated based on the exercise price of the underlying awards and the quoted price of Verisk common stock as of the reporting date. In accordance with ASC 718, Stock Compensation ("ASC 718"), excess tax benefit from exercised stock options and restricted stock lapsed is recorded as an increase to additional paid-in capital and a corresponding reduction in income taxes payable. This tax benefit is calculated as the excess of the intrinsic value of options exercised and restricted stock lapsed in excess of compensation recognized for financial reporting purposes. The amount of the tax benefit that has been realized, as a result of those excess tax benefits, is presented as a financing cash inflow within the accompanying condensed consolidated statements of cash flows. For the nine months ended September 30, 2016 and 2015, the Company recorded excess tax benefits of $18,410 and $18,225, respectively. The Company realized $20,763 and $18,214 of tax benefit within the Company’s quarterly tax payments through September 30, 2016 and 2015, respectively. Stock based compensation expense for the nine months ended September 30, 2016 and 2015 was $23,822 and $25,471, respectively.

The Company estimates expected forfeitures of equity awards at the date of grant and recognizes compensation expense only for those awards that the Company expects to vest. The forfeiture assumption is ultimately adjusted to the actual forfeiture rate. Changes in the forfeiture assumptions may impact the total amount of expense ultimately recognized over the requisite service period and may impact the timing of expense recognized over the requisite service period.

A summary of the status of the restricted stock awarded under the 2013 Incentive Plan as of December 31, 2015 and September 30, 2016 and changes during the interim period are presented below:



	Number of Shares		Weighted Average Grant Date Fair Value Per Share
Outstanding at December 31, 2015	533,768		$	66.25
Granted	262,642		$	80.19
Vested	(229,598	)	$	64.40
Forfeited	(51,481	)	$	72.71
Outstanding at September 30, 2016	515,331		$	71.15

The Company’s employee stock purchase plan (“ESPP”) offers eligible employees the opportunity to purchase shares of the Company’s common stock at a discount of its fair market value at the time of purchase. During the nine months ended September 30, 2016 and 2015, the Company issued 23,168 and 18,171 shares of common stock at a weighted discounted price of $76.64 and $69.14 for the ESPP, respectively.

As of September 30, 2016, there was $66,632 of total unrecognized compensation costs, exclusive of the impact of vesting upon retirement eligibility, related to nonvested share-based compensation arrangements granted under the 2009 and 2013 Incentive Plans. That cost is expected to be recognized over a weighted average period of 2.75 years. As of September 30, 2016, there were 2,647,468 and 514,990 nonvested stock options and restricted stock, respectively, of which 2,221,236 and 433,412 are expected to vest. The total grant date fair value of options vested during the nine months ended September 30, 2016 and 2015 was $10,537 and $14,056, respectively. The total grant date fair value of restricted stock vested during the nine months ended September 30, 2016 and 2015 was $10,580 and $13,536, respectively.

12. Pension and Postretirement Benefits:

The Company maintained a frozen qualified defined benefit pension plan for certain of its employees through membership in the Pension Plan for Insurance Organizations (the “Pension Plan”), a multiple-employer trust. The Company has applied a cash balance formula to determine future benefits. Under the cash balance formula, each participant has an account, which is credited

Table of Contents

annually based on the interest earned on the previous year-end cash balance. The Company also has a frozen non-qualified supplemental cash balance plan (“SERP”) for certain employees. The SERP is funded from the general assets of the Company.

The Company also provides certain healthcare and life insurance benefits to certain qualifying active and retired employees. The Postretirement Health and Life Insurance Plan (the “Postretirement Plan”), which has been frozen, is contributory, requiring participants to pay a stated percentage of the premium for coverage. The components of net periodic (benefit) cost for the three and nine months ended September 30, are summarized below:



	Pension Plan and SERP						Postretirement Plan
	For the Three Months Ended September 30,
	2016			2015			2016			2015
Interest cost	$	4,883		$	4,533		$	90		$	122
Expected return on plan assets		(7,891	)		(8,608	)		(114	)		(137	)
Amortization of prior service credit		—			—			(38	)		(35	)
Amortization of net actuarial loss		941			714			35			108
Net periodic (benefit) cost	$	(2,067	)	$	(3,361	)	$	(27	)	$	58
Employer contributions, net	$	299		$	306		$	345		$	(188	)



	For the Nine Months Ended September 30,
	2016			2015			2016			2015
Interest cost	$	14,445		$	13,577		$	330		$	390
Expected return on plan assets		(23,795	)		(25,824	)		(362	)		(422	)
Amortization of prior service credit		—			—			(110	)		(110	)
Amortization of net actuarial loss		2,529			2,121			285			420
Net periodic (benefit) cost	$	(6,821	)	$	(10,126	)	$	143		$	278
Employer contributions, net	$	842		$	801		$	450		$	(97	)

The expected contributions to the Pension Plan, SERP and Postretirement Plan for the year ending December 31, 2016 are consistent with the amounts previously disclosed as of December 31, 2015.

13. Segment Reporting:

ASC 280-10, Disclosures About Segments of an Enterprise and Related Information (“ASC 280-10”), establishes standards for reporting information about operating segments. ASC 280-10 requires that a public business enterprise reports financial and descriptive information about its operating segments.

Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company’s President and Chief Executive Officer is identified as the CODM as defined by ASC 280-10. Consistent with the internal management of the Company’s business operations based on service offerings, the Company is organized into the following two operating segments, which are also the Company’s reportable segments:

Decision Analytics: The Company develops solutions that its customers use to analyze the key processes in managing risk: ‘prediction of loss’, ‘detection and prevention of fraud’ and ‘quantification of loss’. The Company’s combination of algorithms and analytic methods incorporates its proprietary data to generate solutions. In most cases, the Company’s customers integrate the solutions into their models, formulas or underwriting criteria in order to predict potential loss events, such as hurricanes and earthquakes claims. The Company develops catastrophe and extreme event models and offers solutions covering natural and man-made risks, including acts of terrorism. The Company also develops solutions that allow customers to quantify costs after loss events occur. Fraud solutions include data on claim histories, analysis of claims to find emerging patterns of fraud, and identification of suspicious claims in the insurance sectors. The Company offers services and a suite of solutions to a client base that includes credit and debit card issuers, retail bank and other consumer financial services providers, payment processors, insurance companies and other industry stakeholders. The Company further leverages predictive models and proprietary data to advise customers to make asset investment and portfolio allocation decisions in the global energy market. The Company discloses revenue within this segment based on the industry vertical groupings of insurance, financial services, and energy and specialized markets. On June 1, 2016, the Company sold its healthcare business, Verisk Health, which was part of the Decision Analytics segment. Results of operations for the healthcare business are reported as a discontinued operation for the three and nine months ended September 30, 2016 and 2015. Refer to Note 6 for more information.

Table of Contents

Risk Assessment: The Company is the leading provider of statistical, actuarial and underwriting data for the U.S. P&C insurance industry. The Company’s databases include cleansed and standardized records describing premiums and losses in insurance transactions, casualty and property risk attributes for commercial buildings and their occupants and fire suppression capabilities of municipalities. The Company uses this data to create policy language and proprietary risk classifications that are industry standards and to generate prospective loss cost estimates used to price insurance policies.

The two aforementioned operating segments represent the segments for which discrete financial information is available and upon which operating results are regularly evaluated by the CODM in order to assess performance and allocate resources. The Company uses EBITDA as the profitability measure for making decisions regarding ongoing operations. EBITDA is net income before interest expense, provision for income taxes, depreciation and amortization of fixed and intangible assets. EBITDA is the measure of operating results used to assess corporate performance and optimal utilization of debt and acquisitions. Operating expenses consist of direct and indirect costs principally related to personnel, facilities, software license fees, consulting, travel, and third-party information services. Indirect costs are generally allocated to the segments using fixed rates established by management based upon estimated expense contribution levels and other assumptions that management considers reasonable. The Company does not allocate interest expense and provision for income taxes, since these items are not considered in evaluating the segment’s overall operating performance. In addition, the CODM does not evaluate the financial performance of each segment based on assets. On a geographic basis, revenues from countries outside of the U.S. accounted for 22.0% and 16.6% of the Company's consolidated revenues for the nine months ended September 30, 2016 and 2015, respectively. No individual country outside of the U.S. accounted for 5.0% or more of the Company's consolidated revenues for the nine months ended September 30, 2016 or 2015.

The following table provides the Company’s revenue and EBITDA by reportable segment for the three and nine months ended September 30, 2016 and 2015, and the reconciliation of EBITDA to operating income as shown in the accompanying condensed consolidated statements of operations:



	For the Three Months Ended									For the Three Months Ended
	September 30, 2016									September 30, 2015
	Decision Analytics			Risk Assessment			Total			Decision Analytics			Risk Assessment			Total
Revenues	$	317,307		$	180,774		$	498,081		$	298,681		$	171,727		$	470,408
Expenses:
Cost of revenues (exclusive of items shown separately below)		(117,599	)		(52,066	)		(169,665	)		(114,622	)		(48,252	)		(162,874	)
Selling, general and administrative		(55,378	)		(22,436	)		(77,814	)		(49,386	)		(21,256	)		(70,642	)
Investment income and others, net		583			1,541			2,124			17,910			(16	)		17,894
EBITDA from discontinued operations (including the gain on sale in 2016)		—			—			—			24,050			—			24,050
EBITDA		144,913			107,813			252,726			176,633			102,203			278,836
Depreciation and amortization of fixed assets		(22,585	)		(6,916	)		(29,501	)		(20,368	)		(6,737	)		(27,105	)
Amortization of intangible assets		(22,508	)		(171	)		(22,679	)		(12,551	)		(88	)		(12,639	)
Less: Investment income and others, net		(583	)		(1,541	)		(2,124	)		(17,910	)		16			(17,894	)
EBITDA from discontinued operations (including the gain on sale in 2016)		—			—			—			(24,050	)		—			(24,050	)
Operating income	$	99,237		$	99,185			198,422		$	101,754		$	95,394			197,148
Investment income and others, net								2,124									17,894
Interest expense								(28,150	)								(33,003	)
Income from continuing operations before income taxes							$	172,396								$	182,039

Table of Contents



	For the Nine Months Ended									For the Nine Months Ended
	September 30, 2016									September 30, 2015
	Decision Analytics			Risk Assessment			Total			Decision Analytics			Risk Assessment			Total
Revenues	$	947,431		$	541,646		$	1,489,077		$	768,901		$	514,399		$	1,283,300
Expenses:
Cost of revenues (exclusive of items shown separately below)		(362,631	)		(158,777	)		(521,408	)		(301,660	)		(149,638	)		(451,298	)
Selling, general and administrative		(161,768	)		(62,640	)		(224,408	)		(142,473	)		(60,219	)		(202,692	)
Investment income and others, net		1,575			1,439			3,014			16,962			172			17,134
Gain on derivative instruments		—			—			—			85,187			—			85,187
EBITDA from discontinued operations (including the gain on sale in 2016)		269,485			—			269,485			59,670			—			59,670
EBITDA		694,092			321,668			1,015,760			486,587			304,714			791,301
Depreciation and amortization of fixed assets		(69,978	)		(20,798	)		(90,776	)		(50,119	)		(19,050	)		(69,169	)
Amortization of intangible assets		(69,937	)		(418	)		(70,355	)		(42,733	)		(265	)		(42,998	)
Less: Investment income and others, net		(1,575	)		(1,439	)		(3,014	)		(16,962	)		(172	)		(17,134	)
Gain on derivative instruments		—			—			—			(85,187	)		—			(85,187	)
EBITDA from discontinued operations (including the gain on sale in 2016)		(269,485	)		—			(269,485	)		(59,670	)		—			(59,670	)
Operating income	$	283,117		$	299,013			582,130		$	231,916		$	285,227			517,143
Investment income and others, net								3,014									17,134
Gain on derivative instruments								—									85,187
Interest expense								(91,617	)								(88,927	)
Income from continuing operations before income taxes							$	493,527								$	530,537

Operating segment revenues by type of service is provided below:



	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2016		2015		2016		2015
Decision Analytics:
Insurance	$	174,446	$	162,372	$	521,466	$	481,381
Financial services		33,751		27,104		92,810		88,654
Energy and specialized markets		109,110		109,205		333,155		198,866
Total Decision Analytics		317,307		298,681		947,431		768,901
Risk Assessment:
Industry-standard insurance programs		138,178		131,093		414,204		392,465
Property-specific rating and underwriting information		42,596		40,634		127,442		121,934
Total Risk Assessment		180,774		171,727		541,646		514,399
Total revenues	$	498,081	$	470,408	$	1,489,077	$	1,283,300

Long-lived assets by country are provided below:



	September 30, 2016		December 31, 2015
Long-lived assets:
United States of America	$	1,730,525	$	2,178,142
United Kingdom		2,214,920		2,799,392
Other countries		275,305		11,549
Total long-lived assets	$	4,220,750	$	4,989,083

Table of Contents

14. Related Parties:

The Company considers its stockholders that own more than 5.0% of the outstanding common stock to be related parties as defined within ASC 850, Related Party Disclosures. As of September 30, 2016 and December 31, 2015, the Company had no transactions with related parties owning more than 5.0% of its common stock, except for transactions with the KSOP as disclosed in Note 16 Compensation Plans of the Company's consolidated financial statements included in the 2015 Form 10-K filing.

15. Commitments and Contingencies:

The Company is a party to legal proceedings with respect to a variety of matters in the ordinary course of business, including the matters described below. With respect to ongoing matters, the Company is unable, at the present time, to determine the ultimate resolution of or provide a reasonable estimate of the range of possible loss attributable to these matters or the impact they may have on the Company’s results of operations, financial position or cash flows. This is primarily because the matters are generally in early stages and discovery has either not commenced or been completed. Although the Company believes it has strong defenses and intends to vigorously defend these matters, the Company could in the future incur judgments or enter into settlements of claims that could have a material adverse effect on its results of operations, financial position or cash flows.

Intellicorp Records, Inc. Litigation

On September 9, 2015, the Company was served with a nationwide putative class action complaint filed in the Court of Common Pleas, Cuyahoga County in Ohio naming the Company’s subsidiary Intellicorp Records, Inc. (“Intellicorp.”) titled Sherri Legrand v. Intellicorp Records, Inc. and The Cato Corporation et al. Defendants removed the case to the United States District Court for the Northern District of Ohio on October 8, 2015. Plaintiffs filed their First Amended Class Action Complaint on November 5, 2015 (“Amended Complaint”), which like the prior complaint claims violations of the Fair Credit Reporting Act ("FCRA") and alleges two putative class claims against Intellicorp, namely (i) a section 1681k(a) claim on behalf of all individuals who were the subjects of consumer reports furnished by Intellicorp, which contained public record information in the “Government Sanctions” section of the report on or after September 4, 2013 and continuing through the date the class list is prepared, and (ii) a section 1681e(b) claim on behalf of all individuals who were the subjects of consumer reports furnished by Intellicorp, which contained public record information in the “Government Sanctions” section of the report where the address or social security number of the subject of the report do not match the social security number or address contained in the government database on or after September 4, 2013 and continuing through the date the class list is prepared. Count I of the Amended Complaint alleges that defendant Cato violated the FCRA by procuring consumer reports on the plaintiff and other class members without making the stand-alone disclosure required by FCRA section 1681b(b)(2)(A)(i). Counts II and III allege that Intellicorp violated the FCRA section 1681e (b) by failing to follow reasonable procedures to assure maximum accuracy of the adverse information included in its consumer reports and FCRA section 1681k (a) by failing to maintain strict procedures to assure that the public record information reported, which was likely to have an adverse effect on the consumer was complete and up to date, respectively. The Amended Complaint alleges that defendants acted willfully and seeks statutory damages for the classes in an amount not less than one hundred dollars and not more than one thousand dollars per violation, punitive damages, equitable relief, costs and attorney’s fees.

At this time, it is not possible to determine the ultimate resolution of, or estimate the liability related to this matter.

On February 1, 2016, the Company was served with a nationwide putative class action complaint filed in the United States District Court for the Eastern District of North Carolina naming Intellicorp. The complaint titled Frank DiSalvo v. Intellicorp Records, Inc. claims violations of the FCRA and alleges a section 1681b(b)(1) claim on behalf of all individuals residing in the United States who were the subjects of consumer reports furnished by Intellicorp for employment purposes within the period prescribed by the FCRA, 15 U.S.C. Section 1681p without first obtaining from the user of the report a certification that such user had complied with the obligations under Section 1681b(b)(2) as to the subject of the consumer report. The class complaint alleges that Intellicorp violated the FCRA section 1681b(b)(1) by failing to obtain the required specific certification from its customers to whom Intellicorp furnished consumer reports as to each consumer report provided before providing the specific consumer report that was the subject of the certification. The complaint alleges that the violations were willful or in the alternative negligent and seeks statutory damages for the class in an amount not less than one hundred dollars and not more than one thousand dollars per violation, punitive damages, equitable relief, costs and attorney’s fees. On April 18, 2016, the parties filed a joint motion to stay all proceedings pending the resolution of the United States Supreme Court’s decision in Spokeo v. Robins, No. 13-1339. After Spokeo was decided on May 16, 2016, plaintiffs voluntarily dismissed their federal court complaint and filed a virtually identical complaint in Ohio State court on May 27, 2016. Defendants removed that complaint to the United States District Court for the Northern District of Ohio on July 1, 2016, which on defendant’s motion dismissed the complaint for failure to allege Article III standing and remanded the case to Ohio state court on September 27, 2016.

Table of Contents

At this time, it is not possible to determine the ultimate resolution of, or estimate the liability related to this matter.

Xactware Solutions, Inc. Patent Litigation

On October 8, 2015, the Company was served with a summons and complaint in an action titled Eagle View Technologies, Inc. and Pictometry International Group, Inc. v. Xactware Solutions, Inc. and Verisk Analytics, Inc. filed in the United States District Court for the District of New Jersey. The complaint alleges that the Company’s Roof InSight, Property InSight and Aerial Sketch products infringe seven patents owned by Eagle View and Pictometry namely, Patent Nos. 436, 840, 152, 880, 770, 732 and 454 (collectively the “Patents-in-Suit”). On November 30, 2015, plaintiffs filed a First Amended Complaint (“First Amended Complaint”) adding Patent Nos. 376 and 737 to the Patents in Suit. The First Amended Complaint seeks an entry of judgment by the Court that defendants have and continue to directly infringe and/or indirectly infringe, by way of inducement the Patents-in-Suit, permanent injunctive relief, damages, costs and attorney’s fees.

At this time, it is not possible to determine the ultimate resolution of, or estimate the liability related to this matter.

Interthinx, Inc. Litigation

On April 20, 2015, the Company was served with a putative class action titled John Weber v. Interthinx, Inc. and Verisk Analytics, Inc. The plaintiff, a former employee of the Company’s former subsidiary Interthinx, Inc. in Missouri, filed the class action complaint in the United States District Court for the Eastern District of Missouri on behalf of all review appraisers and individuals holding comparable positions with different titles who were employed by Interthinx for the last three years nationwide and who were not paid overtime wages. The class complaint claims that the review appraiser employees were misclassified as exempt employees and, as a result, were denied certain wages and benefits that would have been received if they were properly classified as non-exempt employees. It pleads a Collective Action under section 216(b) of the Fair Labor Standards Act for unpaid overtime and seeks overtime wages, liquidated damages, declaratory relief, interest, costs and attorneys’ fees.

On March 11, 2014, the Company sold 100 percent of the stock of Interthinx, Inc. At this time, it is not possible to determine the ultimate resolution of, or estimate the liability related to this matter.

Insurance Services Office, Inc. Litigation

On August 1, 2014 the Company was served with an Amended Complaint filed in the United States District Court for the District of Colorado titled Snyder, et. al. v. ACORD Corp., et al. The action is brought by nineteen individual plaintiffs, on their own behalf and on behalf of a putative class, against more than 120 defendants, including the Company and ISO. Except for the Company, ISO and the defendant Acord Corporation, which provides standard forms to assist in insurance transactions, most of the other defendants are property and casualty insurance companies that plaintiffs claim conspired to underpay property damage claims. Plaintiffs claim that the Company and ISO, along with all of the other defendants, violated state and federal antitrust and racketeering laws as well as state common law. On September 8, 2014, the Court entered an Order striking the Amended Complaint and granting leave to the plaintiffs to file a new complaint. On October 13, 2014, plaintiffs filed their Second Amended Complaint, which was re-filed by plaintiffs to correct errors as the Third Amended Complaint. The Third Amended Complaint similarly alleges that the defendants conspired to underpay property damage claims, but does not specifically allege what role the Company or ISO played in the alleged conspiracy. It claims that the Company and ISO, along with all of the other defendants, violated state and federal antitrust and racketeering laws as well as state common law, and seeks all available relief including injunctive, statutory, actual and punitive damages as well as attorneys’ fees. On January 15, 2016, the Court granted defendants’ motions to dismiss all claims asserted in the Third Amended Complaint. Plaintiffs filed a motion for reconsideration of this dismissal on February 16, 2016. The Court granted defendants’ motion to strike the motion for reconsideration on March 2, 2016 and gave plaintiffs leave to file another motion for reconsideration in accordance with the rules which plaintiffs filed on March 11, 2016 and, which was denied by the Court on April 25, 2016. On April 1, 2016, plaintiffs also filed a Notice of Appeal of the Court’s January 15, 2016 Order, which dismissed all claims in the Third Amended Complaint. Plaintiffs also filed an appeal of the Court’s denial of the motion for reconsideration, which the Court of Appeals for the 10th Circuit consolidated with the appeal of the Court’s January 15, 2016 dismissal. Appellants filed their brief in support of the consolidated appeal on July 21, 2016 and Appellees filed their brief in response on September 21, 2016.

At this time, it is not possible to determine the ultimate resolution of, or estimate the liability related to this matter.

On February 19, 2016, the Company was served with a notice of a summons and complaint filed on January 29, 2016 against ISO in the U.S. District Court for the District of Connecticut titled Halloran et al. v. Harleysville Preferred Insurance Co. et al. As alleged in the First Amended Complaint, the putative class action is brought by four policyholders on behalf of a class of similarly situated policyholders in eastern Connecticut who allege that their homeowner’s insurance carriers have denied or will deny their claims for damage to their homes caused by defective concrete. The lawsuit alleges a breach of contract claim against

Table of Contents

certain insurers and seeks declaratory relief as to more than 100 other insurers. It also alleges that ISO as the drafter of the standardized policy language at issue violated the Connecticut Unfair Trade Practices ("CUTPA") and the Connecticut Unfair Insurance Practices Act ("CUIPA"). The plaintiffs ask that the Court certify a class of persons similarly situated and seek relief in the form of the cost for the replacement of their concrete foundations, and a declaratory judgment that all of the defendant insurance carriers are obligated to provide coverage for claims resulting from the defective concrete as well as, attorneys’ fees, costs and interest. On March 17, 2016 plaintiffs filed their first amended complaint asserting federal jurisdiction under the Class Action Fairness Act, adding a number of insurer defendants and amending their damages claim to include punitive damages. After defendants indicated that they would be filing motions to dismiss the first amended complaint at a Rule 16 Conference on April 12, 2016, the Court gave plaintiffs until May 6, 2016 to move for leave to file a second amended complaint. On May 6, 2016, plaintiffs filed a Motion to amend the first amended complaint with a proposed second amended complaint, which did not name ISO or the Company as a defendant. No opposition was filed to the motion to amend, which was granted on October 4, 2016. Instead of filing a second amended complaint, plaintiffs, in a joint motion for the modification of the case schedule filed on October 13, 2016, expressed their intention to move for leave to file a third amended complaint in order to drop certain additional defendants and to add other named plaintiffs.

At this time, it is not possible to determine the ultimate resolution of, or estimate the liability related to this matter.

Table of Contents



Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our historical financial statements and the related notes included in our annual report on Form 10-K, or 2015 10-K, dated and filed with the Securities and Exchange Commission on February 24, 2016. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those discussed in or implied by any of the forward-looking statements as a result of various factors, including but not limited to those listed under “Risk Factors” and “Special Note Regarding Forward Looking Statements” in our 2015 10-K.

We enable risk-bearing businesses to better understand and manage their risks and opportunities associated with those risks. We provide value to our customers by supplying proprietary data that, combined with our analytic methods, creates embedded decision support solutions. We are one of the largest aggregators and providers of data and analytics pertaining to U.S. property and casualty, or P&C, insurance risks. We offer predictive analytics and decision support solutions to customers in rating, underwriting, claims, catastrophe and weather risk, global risk analytics, natural resources intelligence, economic forecasting, and many other fields.

Our customers use our solutions to make better risk decisions with greater efficiency and discipline. We refer to these products and services as “solutions” due to the integration among our products and the flexibility that enables our customers to purchase components or the comprehensive package of products. These solutions take various forms, including data, statistical models or tailored analytics, all designed to allow our clients to make more logical decisions. We believe our solutions for analyzing risk positively impact our customers' revenues and help them better manage their costs.

We organize our business in two segments: Risk Assessment and Decision Analytics. Our Risk Assessment segment provides statistical, actuarial and underwriting data for the U.S. P&C insurance industry. Our Risk Assessment segment revenues represented approximately 36.4% and 40.1% of our revenues for the nine months ended September 30, 2016 and 2015, respectively. Our Decision Analytics segment provides solutions to our customers within three vertical market-related groupings of insurance, financial services, and energy and specialized markets. Our Decision Analytics segment revenues represented approximately 63.6% and 59.9% of our revenues for the nine months ended September 30, 2016 and 2015, respectively.

Discontinued Operations

On June 1, 2016, we sold 100 percent of the stock of the healthcare business, or Verisk Health, in exchange for a purchase price that consisted of $719.4 million of cash consideration after a working capital adjustment of $0.6 million, a subordinated promissory note with a face value of $100.0 million and an eight year maturity, or the Note, and other contingent consideration, or collectively, the Sale. We recognized income from the discontinued operation, net of tax, of $0.0 million and $137.9 million for the three and nine months ended September 30, 2016, respectively. Results of operations for the healthcare business are reported as a discontinued operation for the three and nine months ended September 30, 2016 and for all prior periods presented. See Note 6 of our condensed consolidated financial statements included in this Form 10-Q. As necessary, all amounts have been retroactively adjusted in all periods presented to give recognition to this discontinued operation.

Table of Contents

Executive Summary

Key Performance Metrics

We believe our business' ability to generate recurring revenue and positive cash flow is the key indicator of the successful execution of our business strategy. We use year-over-year revenue growth and EBITDA margin as metrics to measure our performance. EBITDA and EBITDA margin are non-GAAP financial measures (See footnote 1 within the Condensed Consolidated Results of Operations section of Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations). The respective GAAP financial measures are net income and net income margin.

Revenue growth. We use year-over-year revenue growth as a key performance metric. We assess revenue growth based on our ability to generate increased revenue through increased sales to existing customers, sales to new customers, sales of new or expanded solutions to existing and new customers, and strategic acquisitions of new businesses.

EBITDA margin. We use EBITDA margin as a metric to assess segment performance and scalability of our business. We assess EBITDA margin based on our ability to increase revenues while controlling expense growth.

Revenues

We earn revenues through subscriptions, long-term agreements and on a transactional basis. Subscriptions for our solutions are generally paid in advance of rendering services either quarterly or in full upon commencement of the subscription period, which is usually for one year and automatically renewed each year. As a result, the timing of our cash flows generally precedes our recognition of revenues and income and our cash flow from operations tends to be higher in the first quarter as we receive subscription payments. Examples of these arrangements include subscriptions that allow our customers to access our standardized coverage language, our claims fraud database or our actuarial services throughout the subscription period. In general, we experience minimal revenue seasonality within the business. Our long-term agreements are generally for periods of three to five years. We recognize revenue from subscriptions ratably over the term of the subscription and most long-term agreements are recognized ratably over the term of the agreement.

Approximately 90.8% and 89.9% of the revenues in our Risk Assessment segment for the nine months ended September 30, 2016 and 2015, respectively, were derived from subscriptions and long-term agreements for our solutions. Our customers in this segment include most of the P&C insurance providers in the United States. Approximately 77.6% and 77.5% of the revenues in our Decision Analytics segment, for the nine months ended September 30, 2016 and 2015, respectively, were derived from subscriptions and long-term agreements for our solutions. In this segment, our customer bases are within the insurance, financial services, and energy and specialized markets verticals.

Certain of our solutions are also paid for by our customers on a transactional basis. For example, we have solutions that allow our customers to access property-specific rating and underwriting information to price a policy on a commercial building, or compare a P&C insurance, or workers' compensation claim, with information in our databases. For the nine months ended September 30, 2016, and 2015, approximately 17.6% and 17.5%, respectively, of our revenues were derived from providing transactional solutions. We earn transactional revenues as our solutions are delivered or services performed. In general, transactions are billed monthly at the end of each month.

Principal Operating Costs and Expenses

Personnel expenses are the major component of both our cost of revenues and selling, general and administrative expenses. Personnel expenses, which represented 59.7% and 61.2% of our total expenses for the nine months ended September 30, 2016 and 2015, respectively, include salaries, benefits, incentive compensation, equity compensation costs, sales commissions, employment taxes, recruiting costs, and outsourced temporary agency costs.

We allocate personnel expenses between two categories, cost of revenues and selling, general and administrative expense, based on the actual costs associated with each employee. We categorize employees who maintain our solutions as cost of revenues, and all other personnel, including executive managers, sales people, marketing, business development, finance, legal, human resources, and administrative services, as selling, general and administrative expenses. A significant portion of our other operating costs, such as facilities and communications, is also either captured within cost of revenues or selling, general and administrative expenses based on the nature of the work being performed.

While we expect to grow our headcount over time to take advantage of our market opportunities, we believe that the economies of scale in our operating model will allow us to grow our personnel expenses at a lower rate than revenues. Historically, our EBITDA margin has improved because we have been able to increase revenues without a proportionate corresponding increase in expenses. However, part of our corporate strategy is to invest in new solutions which may offset margin expansion.

Table of Contents

Cost of Revenues. Our cost of revenues consists primarily of personnel expenses. Cost of revenues also includes the expenses associated with the acquisition and verification of data, the maintenance of our existing solutions and the development and enhancement of our next-generation solutions. Our cost of revenues excludes depreciation and amortization.

Selling, General and Administrative Expenses. Our selling, general and administrative expenses consist primarily of personnel costs. A portion of the other operating costs such as facilities, insurance and communications is also allocated to selling, general and administrative expenses based on the nature of the work being performed by the employee. Our selling, general and administrative expenses exclude depreciation and amortization.

Table of Contents

Condensed Consolidated Results of Operations



	Three Months Ended September 30,						Percentage Change		Nine Months Ended September 30,						Percentage Change
	2016			2015			Percentage Change		2016			2015			Percentage Change

	(In thousands, except for share and per share data)
Statement of income data:
Revenues:
Decision Analytics revenues	$	317,307		$	298,681		6.2	%	$	947,431		$	768,901		23.2	%
Risk Assessment revenues		180,774			171,727		5.3	%		541,646			514,399		5.3	%
Revenues		498,081			470,408		5.9	%		1,489,077			1,283,300		16.0	%
Expenses:
Cost of revenues (exclusive of items shown separately below)		169,665			162,874		4.2	%		521,408			451,298		15.5	%
Selling, general and administrative		77,814			70,642		10.2	%		224,408			202,692		10.7	%
Depreciation and amortization of fixed assets		29,501			27,105		8.8	%		90,776			69,169		31.2	%
Amortization of intangible assets		22,679			12,639		79.4	%		70,355			42,998		63.6	%
Total expenses		299,659			273,260		9.7	%		906,947			766,157		18.4	%
Operating income		198,422			197,148		0.6	%		582,130			517,143		12.6	%
Other income (expense):
Investment income and others, net		2,124			17,894		(88.1	)%		3,014			17,134		(82.4	)%
Gain on derivative instruments		—			—		—	%		—			85,187		(100.0	)%
Interest expense		(28,150	)		(33,003	)	(14.7	)%		(91,617	)		(88,927	)	3.0	%
Total other expense, net		(26,026	)		(15,109	)	72.3	%		(88,603	)		13,394		(761.5	)%
Income before income taxes		172,396			182,039		(5.3	)%		493,527			530,537		(7.0	)%
Provision for income taxes		(44,819	)		(57,858	)	(22.5	)%		(149,484	)		(151,066	)	(1.0	)%
Income from continuing operations		127,577			124,181		2.7	%		344,043			379,471		(9.3	)%
Discontinued operations
Income from discontinued operations		—			11,750		(100.0	)%		256,525			23,770		979.2	%
Provision for income taxes		—			(4,117	)	(100.0	)%		(118,616	)		(9,421	)	1,159.1	%
Income from discontinued operations (2)		—			7,633		(100.0	)%		137,909			14,349		861.1	%
Net Income	$	127,577		$	131,814		(3.2	)%	$	481,952		$	393,820		22.4	%
Basic net income per share:
Income from continuing operations	$	0.76		$	0.74		2.7	%	$	2.04		$	2.32		(12.1	)%
Income from discontinued operations		—			0.04		(100.0	)%		0.82			0.09		811.1	%
Basic net income per share	$	0.76		$	0.78		(2.6	)%	$	2.86		$	2.41		18.7	%
Diluted net income per share:
Income from continuing operations	$	0.74		$	0.73		1.4	%	$	2.01		$	2.27		(11.5	)%
Income from discontinued operations		—			0.04		(100.0	)%		0.80			0.09		788.9	%
Diluted net income per share	$	0.74		$	0.77		(3.9	)%	$	2.81		$	2.36		19.1	%
Weighted average shares outstanding:
Basic		168,874,129			168,739,437		0.1	%		168,541,399			163,656,387		3.0	%
Diluted		171,785,900			172,171,337		(0.2	)%		171,495,189			167,079,550		2.6	%

The financial operating data below sets forth the information we believe is useful for investors in evaluating our overall financial performance:
Other data:
EBITDA (1):
Decision Analytics EBITDA	$	144,913		$	176,633		(18.0	)%	$	694,092		$	486,587		42.6	%
Risk Assessment EBITDA		107,813			102,203		5.5	%		321,668			304,714		5.6	%
EBITDA	$	252,726		$	278,836		(9.4	)%	$	1,015,760		$	791,301		28.4	%
The following is a reconciliation of net income to EBITDA:
Net income	$	127,577		$	131,814		(3.2	)%	$	481,952		$	393,820		22.4	%
Depreciation and amortization of fixed assets and intangible assets from continuing operations		52,180			39,744		31.3	%		161,131			112,167		43.7	%
Interest expense from continuing operations		28,150			33,003		(14.7	)%		91,617			88,927		3.0	%
Provision for income taxes from continuing operations		44,819			57,858		(22.5	)%		149,484			151,066		(1.0	)%
Depreciation, amortization, interest and provision for income taxes from discontinued operations		—			16,417		(100.0	)%		131,576			45,321		190.3	%
EBITDA	$	252,726		$	278,836		(9.4	)%	$	1,015,760		$	791,301		28.4	%

Table of Contents

(1)

EBITDA is the financial measure which management uses to evaluate the performance of our Company. “EBITDA” is defined as net income before interest expense, provision for income taxes, and depreciation and amortization of fixed and intangible assets. In addition, this Management’s Discussion and Analysis of Financial Condition and Results of Operations includes references to EBITDA margin, which is computed as EBITDA divided by revenues. See Note 13 of our condensed consolidated financial statements included in this Form 10-Q filing. Although EBITDA is a non-GAAP financial measure, EBITDA is frequently used by securities analysts, lenders and others in their evaluation of companies. EBITDA has limitations as an analytical tool, and should not be considered in isolation, or as a substitute for an analysis of our results of operations or cash flows from operating activities reported under GAAP. Management uses EBITDA in conjunction with GAAP operating performance measures as part of its overall assessment of company performance. Some of these limitations are:


•	EBITDA does not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments;


•	EBITDA does not reflect changes in, or cash requirements for, our working capital needs;


•	Although depreciation and amortization are noncash charges, the assets being depreciated and amortized often will have to be replaced in the future and EBITDA does not reflect any cash requirements for such replacements; and


•	Other companies in our industry may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure. Please note because EBITDA is calculated from net income, this presentation included EBITDA from discontinued operations of our healthcare business.

(2)

On June 1, 2016, we sold our healthcare business, Verisk Health. Results of operations for the healthcare business are reported as a discontinued operation for the three and nine months ended September 30, 2016 and for all prior periods presented. See Note 6 of our condensed consolidated financial statements included in this Form 10-Q. As necessary, all amounts have been retroactively adjusted in all periods presented to give recognition to this discontinued operation.

Consolidated Results of Continuing Operations

Nine Months Ended September 30, 2016 Compared to Nine Months Ended September 30, 2015

Revenues

Revenues were $1,489.1 million for the nine months ended September 30, 2016 compared to $1,283.3 million for the nine months ended September 30, 2015, an increase of $205.8 million or 16.0%. Excluding revenues of $143.7 million from Wood Mackenzie (for the first and second quarters), Infield, PCI, Greentech Media, Quest Offshore, and RII, collectively referred to as our recent acquisitions, our consolidated revenue growth was $62.1 million or 5.0%. Revenues within our Decision Analytics segment, excluding our recent acquisitions of Wood Mackenzie (for the first and second quarters), Infield, PCI, Greentech Media and Quest Offshore increased by $35.6 million million or 4.9%. Revenue growth within Decision Analytics, excluding recent acquisitions, was primarily driven by increases in our insurance and financial services categories. Revenues in our Risk Assessment segment, excluding our recent acquisition of RII, increased by $26.5 million million or 5.1%. Within Risk Assessment, both industry-standard insurance programs and property-specific rating and underwriting information contributed to its revenue growth. Refer to the Results of Continuing Operations by Segment within this section for further information regarding our revenues.

Cost of Revenues

Cost of revenues was $521.4 million for the nine months ended September 30, 2016 compared to $451.3 million for the nine months ended September 30, 2015, an increase of $70.1 million or 15.5%. Our recent acquisitions accounted for an increase of $51.5 million in cost of revenues, primarily related to salaries and employee benefits. Excluding the impact of our recent acquisitions, our cost of revenues increased $18.6 million or 4.3%. The increase was primarily due to increases in salaries and employee benefits of $16.6 million, information technology expenses of $1.8 million and other operating costs of $0.4 million. These increases were offset by a decrease in data costs of $0.2 million.

Selling, General and Administrative Expenses

Selling, general and administrative expenses, or SGA, were $224.4 million for the nine months ended September 30, 2016 compared to $202.7 million for the nine months ended September 30, 2015, an increase of $21.7 million or 10.7%. Our recent acquisitions accounted for an increase of $11.6 million in SGA. Excluding costs associated with our recent acquisitions, SGA increased $10.1 million or 6.0%. The increase was primarily due to increases in salaries and employee benefits of $4.8 million, professional consulting costs of $2.8 million, information technology expenses of $1.1 million and other general expenses of $1.4 million.

Table of Contents

Depreciation and Amortization of Fixed Assets

Depreciation and amortization of fixed assets was $90.8 million for the nine months ended September 30, 2016 compared to $69.2 million for the nine months ended September 30, 2015, an increase of $21.6 million or 31.2%. The increase in depreciation and amortization of fixed assets includes depreciation and amortization related to Wood Mackenzie, Infield, PCI, Greentech Media, Quest Offshore and RII of $10.8 million. The remaining increase relates to hardware and software developments placed into production to support data capacity expansion and revenue growth.

Amortization of Intangible Assets

Amortization of intangible assets was $70.4 million for the nine months ended September 30, 2016 compared to $42.9 million for the nine months ended September 30, 2015, an increase of $27.5 million or 63.6%. The increase was primarily related to Wood Mackenzie, Infield, PCI, Greentech Media, Quest Offshore and RII, which amounted to $28.2 million, offset by intangible assets that had been fully amortized of $0.7 million.

Investment Income and Others, net

Investment income and others, net was a gain of $3.0 million for the nine months ended September 30, 2016 as compared to $17.1 million for the nine months ended September 30, 2015. The decrease was primarily related to a gain of $15.6 million in connection with the exercise and payout of common stock warrants for the nine months ended September 30, 2015. The remaining increase was mostly attributable to interest income of $3.7 million generated from the subordinated promissory note related to the divestiture of our healthcare business and a gain on sale of non-controlling equity investment in a business of $1.5 million, which were offset by a net loss on foreign currencies.

Gain on derivative instruments

Gain on derivative instruments was $0.0 million for the nine months ended September 30, 2016 as compared to a gain of $85.2 million for the nine months ended September 30, 2015, a decrease of $85.2 million or 100.0%. The decrease is due a one-time foreign currency hedge gain in 2015, which did not recur in 2016.

Interest Expense

Interest expense was $91.7 million for the nine months ended September 30, 2016, compared to $88.9 million for the nine months ended September 30, 2015, an increase of $2.8 million or 3.0%. The increase is primarily due to the interest costs on the debt incurred in connection with the acquisition of Wood Mackenzie.

Provision for Income Taxes

The provision for income taxes was $149.5 million for the nine months ended September 30, 2016 compared to $151.1 million for the nine months ended September 30, 2015, a decrease of $1.6 million or 1.0%. The effective tax rate was 30.3% for the nine months ended September 30, 2016 compared to 28.5% for the nine months ended September 30, 2015. The effective rate for the nine months ended September 30, 2016 was higher than the September 30, 2015 effective tax rate primarily due to non-recurring tax benefits related to the Wood Mackenzie acquisition in 2015.

Net Income Margin

The net income margin for our consolidated results, including discontinued operations, was 30.1% for the nine months ended September 30, 2016 compared to 26.1% for the nine months ended September 30, 2015. Our net income margin for the nine months ended September 30, 2016 was positively impacted by the discontinued operations, including the gain on sale of our healthcare business of 7.0% and lowered by increased amortization of intangible assets associated with our recent acquisitions. Our net income margin for the nine months ended September 30, 2015 was lowered by the discontinued operations of 3.4% and positively impacted by the derivative gain and the transaction costs related to the Wood Mackenzie acquisition of 2.3%, and the gain on the exercise and payout of the common stock warrants of 0.6%.

EBITDA Margin

The EBITDA margin for our consolidated results, including discontinued operations, was 63.4% for the nine months ended September 30, 2016 compared to 52.5% for the nine months ended September 30, 2015. Our EBITDA margin for the nine months ended September 30, 2016 was positively impacted by the discontinued operations, including the gain on sale of our healthcare business, of 13.3%. Our EBITDA margin for the nine months ended September 30, 2015 was lowered by the discontinued operations of 4.5% and positively impacted by the derivative gain and the transaction costs related to the Wood Mackenzie acquisition of 3.9%, and the gain on the exercise and payout of the common stock warrants of 1.0%.

Table of Contents

Three Months Ended September 30, 2016 Compared to Three Months Ended September 30, 2015

Revenues

Revenues were $498.1 million for the three months ended September 30, 2016 compared to $470.4 million for the three months ended September 30, 2015, an increase of $27.7 million or 5.9%. Excluding revenues of $5.7 million from Infield, PCI, Greentech Media, and Quest Offshore, our recent acquisitions within the Decision Analytics segment, and RII, our recent acquisition within the Risk Assessment segment, all collectively referred to as our recent acquisitions, our consolidated revenue growth increased $22.0 million or 4.7%. Revenues within our Decision Analytics segment, excluding our recent acquisitions of Infield, PCI, Greentech Media, and Quest Offshore, increased by $13.4 million or 4.5% and revenues in our Risk Assessment segment, excluding our recent acquisition of RII, increased by $8.6 million or 5.0%. Revenue growth within Decision Analytics, excluding recent acquisitions, was primarily driven by increases in our insurance and financial services categories. Within Risk Assessment, both industry-standard insurance programs and property-specific rating and underwriting information contributed to its revenue growth. Refer to the Results of Continuing Operations by Segment within this section for further information regarding our revenues.

Cost of Revenues

Cost of revenues was $169.7 million for the three months ended September 30, 2016 compared to $162.9 million for the three months ended September 30, 2015, an increase of $6.8 million or 4.2%. Our recent acquisitions accounted for an increase of $3.6 million in cost of revenues, primarily related to salaries and employee benefits. Excluding the impact of our recent acquisitions, our cost of revenues increased $3.2 million or 2.0%. The increase was primarily due to increases in salaries and employee benefits of $3.0 million (including a non-recurring severance cost), data costs of $1.1 million and information technology expenses of $0.4 million. These increases were offset by a decrease in other operating costs of $1.3 million.

Selling, General and Administrative Expenses

Selling, general and administrative expenses, or SGA, were $77.8 million for the three months ended September 30, 2016 compared to $70.6 million for the three months ended September 30, 2015, an increase of $7.2 million or 10.2%. Our recent acquisitions accounted for an increase of $1.3 million in SGA. Excluding costs associated with our recent acquisitions, SGA increased $5.9 million or 8.2%. The increase was primarily due to increases in professional consulting costs of $3.8 million, salaries and employee benefits of $1.8 million and information technology expenses of $0.6 million. These increases were offset by a decrease in other general expenses of $0.3 million.

Depreciation and Amortization of Fixed Assets

Depreciation and amortization of fixed assets was $29.5 million for the three months ended September 30, 2016 compared to $27.1 million for the three months ended September 30, 2015, an increase of $2.4 million or 8.8%. The increase in depreciation and amortization of fixed assets includes depreciation and amortization related to our recent acquisitions and capital expenditures.

Amortization of Intangible Assets

Amortization of intangible assets was $22.7 million for the three months ended September 30, 2016 compared to $12.6 million for the three months ended September 30, 2015, an increase of $10.1 million or 79.4%. The increase was primarily related to Wood Mackenzie, Infield, PCI, Greentech Media, Quest Offshore and RII, which amounted to $10.2 million.

Investment Income and Others, net

Investment income and others, net was a gain of $2.1 million for the three months ended September 30, 2016 as compared to $17.9 million for the three months ended September 30, 2015. The decrease was primarily related to a gain of $15.6 million in connection with the exercise and payout of common stock warrants for the nine months ended September 30, 2015.

Interest Expense

Interest expense was $28.1 million for the three months ended September 30, 2016, compared to $33.0 million for the three months ended September 30, 2015, a decrease of $4.9 million or 14.7%. The decrease is primarily due to repayments on the Credit Facility funded by the net proceeds from the divestiture of our healthcare business and cash from operations.

Table of Contents

Provision for Income Taxes

The provision for income taxes was $44.8 million for the three months ended September 30, 2016 compared to $57.9 million for the three months ended September 30, 2015, a decrease of $13.1 million or 22.5%. The effective tax rate was 26.0% for the three months ended September 30, 2016 compared to 31.8% for the three months ended September 30, 2015. The effective rate for the three months ended September 30, 2016 was lower than the September 30, 2015 effective tax rate primarily due to tax benefits of legislation enacted in the United Kingdom lowering future income tax rates.

Net Income Margin

The net income margin for our consolidated results, including discontinued operations, was 25.6% for the three months ended September 30, 2016 compared to 23.9% for the three months ended September 30, 2015. The discontinued operations lowered our net income margin by 2.5%, which was offset by 1.8% resulting from the gain on the exercise and payout of the common stock warrants for the three months ended September 30, 2015.

EBITDA Margin

The EBITDA margin for our consolidated results, including discontinued operations, was 50.7% for the three months ended September 30, 2016 and 2015. The discontinued operations lowered our EBITDA margin by 3.5%, which was offset by 2.8% resulting from the gain on the exercise and payout of the common stock warrants for the three months ended September 30, 2015.

Results of Continuing Operations by Segment

Decision Analytics

Revenues

Revenues for our Decision Analytics segment were $947.4 million for the nine months ended September 30, 2016 compared to $768.9 million for the nine months ended September 30, 2015, an increase of $178.5 million or 23.2%. Excluding revenue of $142.9 million from Wood Mackenzie (for the first and second quarters) and our recent acquisitions, Decision Analytics revenue increased by $35.6 million or 4.9%.

Our revenue by category for the periods presented is set forth below:



	For the Nine Months Ended September 30,				Percentage
	2016		2015		Change

	(In thousands)
Insurance	$	521,466	$	481,381	8.3	%
Financial services		92,810		88,654	4.7	%
Energy and specialized markets		333,155		198,866	67.5	%
Total Decision Analytics	$	947,431	$	768,901	23.2	%

Our insurance revenue increased $40.0 million or 8.3%, primarily due to increases within our loss quantification solutions, claims analytics, underwriting and catastrophe modeling solutions. Loss quantification in 2016 benefited from a non-recurring partnership revenue.

Our financial services revenue increased $4.2 million or 4.7%, primarily due to the continued demand for our analytic solutions and services.

Our energy and specialized markets revenue increased $134.3 million or 67.5%; excluding revenues of $142.9 million from Wood Mackenzie (for the first and second quarters) and our recent acquisitions of Infield, PCI, Greentech Media and Quest Offshore, our energy and specialized markets revenue decreased $8.6 million or 5.4% due to declines in our research analytic solutions and environmental health and safety services.

Revenues for our Decision Analytics segment were $317.3 million for the three months ended September 30, 2016 compared to $298.6 million for the three months ended September 30, 2015, an increase of $18.7 million or 6.2%. Excluding revenue of $5.3 million from our recent acquisitions, Decision Analytics revenue increased by $13.4 million or 4.5%.

Table of Contents

Our revenue by category for the periods presented is set forth below:



	For the Three Months Ended September 30,				Percentage
	2016		2015		Change

	(In thousands)
Insurance	$	174,446	$	162,372	7.4	%
Financial services		33,751		27,104	24.5	%
Energy and specialized markets		109,110		109,205	(0.1	)%
Total Decision Analytics	$	317,307	$	298,681	6.2	%

Our insurance revenue increased $12.0 million or 7.4%, primarily due to increases within our underwriting, claims analytics, catastrophe modeling solutions and loss quantification solutions.

Our financial services revenue increased $6.8 million or 24.5%, primarily due to the continued demand for our analytical solutions and media effectiveness.

Our energy and specialized markets revenue decreased $0.1 million or 0.1%; excluding revenues from recent acquisitions, Infield, PCI, Greentech Media and Quest Offshore of $5.3 million, our energy and specialized markets revenue decreased $5.4 million or 4.9%, primarily as a result of continuing end-market and currency headwinds affecting the energy business.

Cost of Revenues

Cost of revenues for our Decision Analytics segment was $362.6 million for the nine months ended September 30, 2016 compared to $301.7 million for the nine months ended September 30, 2015, an increase of $60.9 million or 20.2%. Our recent acquisitions within the Decision Analytics segment, represented an increase of $50.9 million in cost of revenues, which was primarily related to salaries and employee benefits. Excluding the impact of our recent acquisitions, our cost of revenues increased $10.0 million or 3.6%. The increase was primarily due to increases in salaries and employee benefits of $9.7 million, information technology expenses of $1.2 million. These increases were offset by decreases in data costs of $0.6 million and other operating costs of $0.3 million.

Cost of revenues for our Decision Analytics segment was $117.6 million for the three months ended September 30, 2016 compared to $114.6 million for the three months ended September 30, 2015, an increase of $3.0 million or 2.6%. Our recent acquisitions within the Decision Analytics segment, represented an increase of $3.2 million in cost of revenues, which was primarily related to salaries and employee benefits. Excluding the impact of our recent acquisitions, our cost of revenues decreased $0.2 million or 0.2%. The decrease was primarily due to a decrease in other operating costs of $1.8 million, which was offset by increases in data costs of $0.8 million, salaries and employee benefits of $0.7 million and information technology expenses of $0.1 million.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for our Decision Analytics segment were $161.8 million for the nine months ended September 30, 2016 compared to $142.5 million for the nine months ended September 30, 2015, an increase of $19.3 million or 13.5%. Our recent acquisitions within the Decision Analytics segment, accounted for an increase of $11.6 million in SGA, which was primarily related to salaries and employee benefits. Excluding costs associated with our recent acquisitions, SGA increased $7.7 million or 7.1%. The increase was primarily due to increases in salaries and employee benefits of $5.4 million, professional consulting fees of $1.4 million, information technology expenses of $0.7 million and other general expenses of $0.2 million.

Selling, general and administrative expenses for our Decision Analytics segment were $55.4 million for the three months ended September 30, 2016 compared to $49.3 million for the three months ended September 30, 2015, an increase of $6.1 million or 12.1%. Our recent acquisitions within the Decision Analytics segment, accounted for an increase of $1.4 million in SGA. Excluding costs associated with our recent acquisitions, SGA increased $4.7 million or 9.4%. The increase was primarily due to increases in salaries and employee benefits of $2.9 million, professional consulting fees of $2.9 million and information technology expenses of $0.3 million. These increases were offset by a decrease in other operating costs of $1.4 million.

Table of Contents

EBITDA Margin

The EBITDA margin for our Decision Analytics segment, including discontinued operations, was 65.5% for the nine months ended September 30, 2016 compared to 49.0% for the nine months ended September 30, 2015. The discontinued operations lowered our EBITDA margin by 6.5% for the nine months ended September 30, 2015. The increase in our EBITDA margin was primarily attributed to the gain on sale from the divestiture of our healthcare business.

Risk Assessment

Revenues

Revenues for our Risk Assessment segment were $541.7 million for the nine months ended September 30, 2016 compared to $514.4 million for the nine months ended September 30, 2015, an increase of $27.3 million or 5.3%. Excluding the acquisition of RII, revenue for our Risk Assessment increased $26.5 million or 5.1% for the nine months ended September 30, 2016. Revenues for our Risk Assessment segment were $180.8 million for the three months ended September 30, 2016 compared to $171.8 million for the three months ended September 30, 2015, an increase of $9.0 million or 5.3%. Excluding the acquisition of RII, revenue for our Risk Assessment increased $8.6 million or 5.0% for the three months ended September 30, 2016. The overall increase within this segment primarily resulted from an increase in prices derived from continued enhancements to the content of our industry-standard insurance programs' solutions as well as selling expanded solutions to existing customers.

Our revenue by category for the periods presented is set forth below:



	Three Months Ended September 30,				Percentage		Nine Months Ended September 30,				Percentage
	2016		2015		Change		2016		2015		Change

	(In thousands)						(In thousands)
Industry-standard insurance programs	$	138,178	$	131,093	5.4	%	$	414,204	$	392,465	5.5	%
Property-specific rating and underwriting information		42,596		40,634	4.8	%		127,442		121,934	4.5	%
Total Risk Assessment	$	180,774	$	171,727	5.3	%	$	541,646	$	514,399	5.3	%

Cost of Revenues

Cost of revenues for our Risk Assessment segment was $158.8 million for the nine months ended September 30, 2016 compared to $149.6 million for the nine months ended September 30, 2015, an increase of $9.2 million or 6.1%. The increase was primarily due to increases in salaries and employee benefits costs of $6.9 million, information technology expenses of $0.6 million, data costs of $0.4 million, expenses incurred in connection with our recent acquisition of $0.6 million and other operating costs of $0.7 million.

Cost of revenues for our Risk Assessment segment was $52.1 million for the three months ended September 30, 2016 compared to $48.3 million for the three months ended September 30, 2015, an increase of $3.8 million or 7.9%. The increase was primarily due to increases in salaries and employee benefits costs of $2.3 million, information technology expenses of $0.3 million, data costs of $0.3 million, expenses incurred in connection with our recent acquisition of $0.4 million and other operating costs of $0.5 million.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for our Risk Assessment segment were $62.6 million for the nine months ended September 30, 2016 compared to $60.2 million for the nine months ended September 30, 2015, an increase of $2.4 million or 4.0%. The increase was primarily due to increases in professional consulting costs of $1.4 million, information technology expenses of $0.4 million and other general expense of $1.2 million. These increases were offset by a decrease in salaries and employee benefits of $0.6 million.

Selling, general and administrative expenses for our Risk Assessment segment were $22.4 million for the three months ended September 30, 2016 compared to $21.3 million for the three months ended September 30, 2015, an increase of $1.1 million or 5.5%. The increase was primarily due to increases in professional consulting costs of $0.9 million, information technology expenses of $0.3 million and other general expense of $1.0 million. These increases were offset by a decrease in salaries and employee benefits of $1.1 million.

Table of Contents

EBITDA Margin

EBITDA margin for our Risk Assessment segment was 59.4% for the nine months ended September 30, 2016 compared to 59.2% for the nine months ended September 30, 2015. The increase in our EBITDA margin was primarily attributed to enhanced operating leverage in the segment as well as cost efficiencies.

Liquidity and Capital Resources

As of September 30, 2016 and December 31, 2015, we had cash and cash equivalents and available-for-sale securities of $168.2 million and $141.9 million, respectively. Subscriptions for our solutions are billed and generally paid in advance of rendering services either quarterly or upon commencement of the annual or multi-year subscription period in annual amounts. Most of our subscriptions are automatically renewed at the beginning of each calendar year. We have historically generated significant cash flows from operations. As a result of this factor, as well as the availability of funds under our $1,500.0 million Syndicated Revolving Credit Facility, or the Credit Facility, we believe that we will have sufficient cash to meet our working capital and capital expenditure needs, and to fuel our future growth plans.

We have historically managed the business with a working capital deficit due to the fact that, as described above, we offer our solutions and services primarily through annual subscriptions or long-term contracts, which are generally prepaid quarterly or annually in advance of the services being rendered. When cash is received for prepayment of invoices, we record an asset (cash and cash equivalents) on our balance sheet with the offset recorded as a current liability (fees received in advance). This current liability is deferred revenue that does not require a direct cash outflow since our customers have prepaid and are obligated to purchase the services. In most businesses, growth in revenue typically leads to an increase in the accounts receivable balance causing a use of cash as a company grows. Unlike those businesses, our cash position is favorably affected by revenue growth, which results in a source of cash due to our customers prepaying for most of our services.

Our capital expenditures as a percentage of consolidated revenues for the nine months ended September 30, 2016 and 2015, were 6.2% and 7.0%, respectively. The expected capital expenditures for the year ending December 31, 2016 will be approximately $155.0 million, which we expect to primarily include expenditures on our technology infrastructure and our continuing investments in developing and enhancing our solutions. Expenditures related to developing and enhancing our solutions are predominately related to internal use software and are capitalized in accordance with ASC 350-40, "Accounting for Costs of Computer Software Developed or Obtained for Internal Use." We also capitalize amounts in accordance with ASC 985-20, "Software to be Sold, Leased or Otherwise Marketed."

We have also historically used a portion of our cash for repurchases of our common stock from our stockholders. During the nine months ended September 30, 2016, we repurchased $189.8 million of our common stock. There were no stock repurchases during the nine months ended September 30, 2015.

Financing and Financing Capacity

We had total debt, excluding capital lease obligations and the discounts and debt issuance costs on our senior notes, of $2,300.0 million and $3,170.0 million at September 30, 2016 and December 31, 2015, respectively. The debt at September 30, 2016 was primarily issued under senior notes in May 2015 and during 2012 and 2011. As of September 30, 2016, we had senior notes with an aggregate principal amount of $2,300.0 million outstanding, and we were in compliance with our financial debt covenants.

As of September 30, 2016, we had a borrowing capacity of $1,500.0 million of which $1,497.5 million was available for borrowings under the Credit Facility with Bank of America N.A., JP Morgan Chase, N.A., and a syndicate of banks. The Credit Facility may be used for general corporate purposes, including working capital needs and capital expenditures, acquisitions and the share repurchase program.

The Credit Facility contains certain financial and other covenants that, among other things, impose certain restrictions on indebtedness, liens, investments, and capital expenditures. These covenants also place restrictions on mergers, asset sales, sale/leaseback transactions, payments between us and our subsidiaries, and certain transactions with affiliates. The financial covenants require that, at the end of any fiscal quarter, we have a consolidated interest coverage ratio of at least 3.0 to 1.0 and that we maintain, during any period of four fiscal quarters, a consolidated funded debt leverage ratio of 3.5 to 1.0. We were in compliance with all financial debt covenants under the Credit Facility as of September 30, 2016. During the nine months ended September 30, 2016, we had total combined borrowings under the Credit Facility of $40.0 million and repaid $910.0 million. Interest on borrowings under the Credit Facility is payable at an interest rate of LIBOR plus 1.125% to 1.625%, depending upon the consolidated funded debt leverage ratio. A commitment fee on any unused balance is payable periodically and will range from 12.5 to 25.0 basis points based upon the consolidated funded debt leverage ratio. As of September 30, 2016 and December 31, 2015, we had outstanding borrowings under the Credit Facility of $0.0 million and $870.0 million, respectively. During the nine months ended September 30,

Table of Contents

2016, we utilized a portion of the proceeds from the sale of Verisk Health and cash flows from operations to repay the outstanding borrowings under the Credit Facility. On May 26, 2016, we entered into the Second Amendment to the Credit Facility, which reduced the borrowing capacity from $1,750.0 million to $1,500.0 million and amended the pricing grid. All borrowings under the Credit Facility continue to remain unsecured.

Cash Flow

The following table summarizes our cash flow data for the nine months ended September 30, 2016 and 2015:



	Nine Months Ended September 30,						Percentage Change
	2016			2015			Percentage Change

	(In thousands)
Net cash provided by operating activities	$	463,671		$	520,044		(10.8	)%
Net cash provided by (used in) investing activities	$	579,326		$	(2,895,202	)	120.0	%
Net cash (used in) provided by financing activities	$	(1,007,118	)	$	2,503,235		(140.2	)%

Operating Activities

Net cash provided by operating activities was $463.7 million for the nine months ended September 30, 2016 compared to $520.0 million for the nine months ended September 30, 2015. Excluding the discontinued operations of Verisk Health, net cash provided by operating activities was $442.2 million for the nine months ended September 30, 2016 compared to $467.5 million for the nine months ended September 30, 2015, a decrease of 5.4%. The decrease in net cash provided by operating activities was primarily due to an increase in taxes paid related to the gain on the divestiture of our healthcare business and interest payments on our senior notes that were issued in May 2015, partially offset by an increase in cash receipts from customers driven by an increase in revenues and operating income and additional operating cash flow from Wood Mackenzie.

Investing Activities

Net cash provided by investing activities was $579.3 million for the nine months ended September 30, 2016 and net cash used in investing activities was $2,895.2 million for the nine months ended September 30, 2015. The change in investing activities was primarily due to the net proceeds from the divestiture of our healthcare business on June 1, 2016 and the net of cash acquisition of Wood Mackenzie of $2,889.6 million on May 19, 2015.

Financing Activities

Net cash used in financing activities was $1,007.1 million for the nine months ended September 30, 2016 and net cash provided by financing activities was $2,503.2 million for the nine months ended September 30, 2015, respectively. Net cash used in financing activities for the nine months ended September 30, 2016 was primarily related to net repayments of our Credit Facility of $870.0 million mostly funded by the net proceeds from the divestiture of our healthcare business and the current year repurchases of common stock of $182.5 million partially offset by proceeds and tax benefits from stock option exercises of $53.4 million. Net cash provided by financing activities for the nine months ended September 30, 2015 was primarily related to the net proceeds from the debt and equity offerings of $1,244.0 million and $720.8 million, respectively, and other borrowings from our Credit Facility of $830.0 million, partially offset by repayments from our credit facility and private placement debt of $90.0 million and $220.0 million, respectively.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Contractual Obligations

There have been no material changes to our contractual obligations outside the ordinary course of our business from those reported in our annual report on Form 10-K and filed with the Securities and Exchange Commission on February 24, 2016.

Critical Accounting Policies and Estimates

Our management’s discussion and analysis of financial condition and results of operations are based on our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements require management to make estimates and judgments that affect

Table of Contents

reported amounts of assets and liabilities and related disclosures of contingent assets and liabilities at the dates of the financial statements and revenue and expenses during the reporting periods. These estimates are based on historical experience and on other assumptions that are believed to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates, including those related to acquisition purchase price allocations, revenue recognition, goodwill and intangible assets, pension and other post retirement benefits, stock-based compensation, income taxes and allowance for doubtful accounts. Actual results may differ from these assumptions or conditions. Some of the judgments that management makes in applying its accounting estimates in these areas are discussed under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report on Form 10-K dated and filed with the Securities and Exchange Commission on February 24, 2016. Since the date of our annual report on Form 10-K, there have been no material changes to our critical accounting policies and estimates.

Table of Contents



Item 3.	Quantitative and Qualitative Disclosures About Market Risk

Market risks at September 30, 2016 have not materially changed from those discussed under Item 7A in our annual report on Form 10-K dated and filed with the Securities and Exchange Commission on February 24, 2016.



Item 4.	Controls and Procedures

Disclosure Controls and Procedures

We are required to maintain disclosure controls and procedures (as that term is defined in Rules 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives at the reasonable assurance level.

Our management, with the participation of the Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q. Based upon the foregoing assessments, our Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2016, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

We integrated Wood Mackenzie into our overall internal control over financial reporting process. Other than this integration, during the nine months ended September 30, 2016, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II — OTHER INFORMATION



Item 1.	Legal Proceedings

We are party to legal proceedings with respect to a variety of matters in the ordinary course of business. See Part I Item I. Note 15 to our condensed consolidated financial statements for the nine months ended September 30, 2016 for a description of our significant current legal proceedings, which is incorporated by reference herein.



Item 1A.	Risk Factors

Other than the item below, there has been no material change in the information provided under the heading “Risk Factors” in our annual report on Form 10-K dated and filed with the Securities and Exchange Commission on February 24, 2016:

Economic and political instability and potential unfavorable changes in laws and regulations resulting from the UK’s exit from the European Union could adversely affect our financial condition, results of operations and cash flows.

The results of the referendum on June 23, 2016 in the United Kingdom, or UK, to exit the European Union, or EU, which is commonly referred to as “Brexit,” and to potentially significantly change the UK’s relationship with the EU and the laws and regulations impacting business conducted between the UK and EU countries could disrupt the overall stability of the EU given the diverse economic and political circumstances of individual EU countries and negatively impact our European operations. An immediate consequence of the Brexit vote was an adverse impact to global markets, including currency markets which experienced a sharp drop in the value of the British pound. Longer term, Brexit will require negotiations regarding the future terms of the UK’s relationship with the EU, which could result in the UK losing access to certain aspects of the single EU market and the global trade deals negotiated by the EU on behalf of its members. The Brexit vote and the perceptions as to the impact of the withdrawal of the UK may adversely affect business activity, political stability and economic conditions in the UK, the EU and elsewhere, the impact of which could have an adverse effect our financial condition, results of operations and cash flows.



Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds

Recent Sales of Unregistered Securities

There were no unregistered sales of equity securities by the Company during the period covered by this report.

Issuer Purchases of Equity Securities

Our board of directors has authorized a share repurchase program of up to $2.3 billion. As of September 30, 2016, we had $279.5 million available to repurchase shares. These authorizations have no expiration dates and may be suspended or terminated at any time. Since the introduction of share repurchase as a feature of our capital management strategies in 2010, we have repurchased shares with an aggregate value of $2.0 billion. Our share repurchases for the quarter ended September 30, 2016 are set forth below:



				Total Number of	Approximate Dollar
				Shares Purchased	Value of Shares that
	Total Number	Average		as Part of Publicly	May Yet Be
	of Shares	Price Paid		Announced Plans	Purchased Under the
Period	Purchased	per Share		or Programs	Plans or Programs
						(in thousands)
July 1, 2016 through July 31, 2016	—	$	—	—	$	352,989
August 1, 2016 through August 31, 2016	194,011	$	82.61	194,011	$	336,962
September 1, 2016 through September 30, 2016	704,708	$	81.48	704,708	$	279,545
	898,719			898,719



Item 3.	Defaults Upon Senior Securities

None.

Table of Contents



Item 4.	Mine Safety Disclosures

None.



Item 5.	Other Information

None.



Item 6.	Exhibits

See Exhibit Index.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



	Verisk Analytics, Inc.
	(Registrant)



Date: November 1, 2016	By:	/s/ Eva F. Huston
		Eva F. Huston
		Senior Vice President and Chief Financial Officer
		(Principal Financial Officer and Duly Authorized Officer)

Table of Contents

EXHIBIT INDEX



Exhibit Number		Description
31.1		Certification of the Chief Executive Officer of Verisk Analytics, Inc. pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.*

31.2		Certification of the Chief Financial Officer of Verisk Analytics, Inc. pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.*

32.1		Certification of the Chief Executive Officer and Chief Financial Officer of Verisk Analytics, Inc. pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002.*

101.INS		XBRL Instance Document.*

101.SCH		XBRL Taxonomy Extension Schema.*

101.CAL		XBRL Taxonomy Extension Calculation Linkbase.*

101.DEF		XBRL Taxonomy Definition Linkbase.*

101.LAB		XBRL Taxonomy Extension Label Linkbase.*

101.PRE		XBRL Taxonomy Extension Presentation Linkbase.*



*	Filed herewith.